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Abstract
Individuals with type 2 diabetes (T2D) are prescribed aerobic exercise as treatment,
however, peripheral arterial disease (PAD), a complication of T2D, restricts lower
extremity blood flow causing claudication during the activity. Isometric exercise has
been shown to increase local blood flow in other populations. This thesis tested the
hypothesis that bilateral lower extremity isometric training would increase both initial
(ICD) and absolute claudication distances (ACD) by increasing blood flow. Four males
with T2D and PAD performed 4, 2-minute bilateral lower extremity isometric
contractions at 30% of their maximal effort, 3X/week for 6-8 weeks. Pre and postexercise ICD, ACD and blood flow were measured before and after the intervention.
ICD and ACD increased 116.3+26.3% and 47.5±34.1%, respectively (Z=2.475; p=.008)
with bilateral lower extremity isometric training, however, pre and post-exercise blood
flow remained unchanged. These findings suggest that bilateral lower extremity isometric
training increases ICD and ACD by a mechanism other than increased blood flow.
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CHAPTER 1: Introduction and Literature Review
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1.1 Diabetes Mellitus (DM)
1.1.1 Introduction
Diabetes mellitus (DM) is a disease characterized by elevated blood glucose
(hyperglycemia) due to inadequate insulin secretion or action (Centers for Disease
Control and Prevention, 2010). It affects over 180 million people worldwide, a figure
that will likely double by 2030 (World Health Organization, 2008). DM is a prominent
risk factor for the world's leading cause of death, cardiovascular disease, and over half of
the individuals diagnosed with diabetes die before the age of 70 (World Health
Organization, 2009a; Grundy et al., 1999). The only non-infectious disease classified as
an epidemic, DM is not the result of genetic factors alone, as both the environment and/or
an individual's behaviour (such as a sedentary lifestyle and high calorie diet) often play a
major role in its development (World Health Organization, 2008; Zimmet, Alberti, &
Shaw, 2001).
Before discussing, in detail, the different types of DM, it is important to first
understand blood glucose and its regulation in a healthy population.

1.1.2 Blood Glucose Regulation
Blood Glucose
Glucose, a monosaccharide or simple sugar, is a type of carbohydrate (molecules
composed of atoms of carbon, hydrogen and oxygen), a fuel that can rapidly provide the
body with energy (National Diabetes Information Clearinghouse, 2008). Blood glucose
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refers to the amount of glucose present in blood (Candian Diabetes Association, 2008).
The normal fasting blood glucose level in humans is 4.0 mM-6.0 mM (Canadian Diabetes
Association, 2008). With the ingestion of food or drink composed of this simple sugar,
the blood glucose level will rise and alter the body's internal environment (National
Diabetes Information Clearinghouse, 2008).
Negative Feedback and Blood Glucose Regulation Mechanisms
One of the goals of the human body is to maintain a constant internal environment
or homeostasis. The regulation of blood glucose is accomplished through a negative
feedback system. In general terms, this negative feedback system is composed of three
elements: a sensor, a control center and effectors. A change in the internal environment
acts as a stimulus that is detected by the sensor. The sensor sends a signal to the control
center which assesses the amount of change that has occurred in the internal environment,
then the control center sends the appropriate signal to the effectors. The effectors
produce a response to correct the change in the internal environment that was detected.
This feedback system is considered a negative feedback system because the response it
produces is negative or opposite of the stimulus. (Powers & Howley, 2009)
In relation to blood glucose regulation, a blood glucose concentration that is
elevated above normal (a change in the internal environment) is the stimulus detected by
the sensor (the pancreas) and the signal sent to the effector (also the pancreas) from the
control center is to increase insulin secretion (insulin is responsible for increased glucose
uptake by cells) which, in turn, decreases the blood glucose concentration (see Figure 1)
(Aserita, 1985).

3

Blood glucose regulation mechanisms are responsible for the success of this
negative feedback system. After the digestion of a meal or drink containing
carbohydrates blood glucose levels can increase to levels as high as 8 mM (Jewell, Oh, &
Thurmond, 2010; Canadian Diabetes Association, 2008). The glucose molecules (which
have increased in number) travel through the bloodstream to pancreatic beta-cells (Jewell,
Oh, & Thurmond, 2010). These molecules then attach to the membrane spanning glucose
transporter proteins (GLUT2) of the beta-cell and enter via facilitated diffusion (Inagaki
et al., 1992). While in the beta-cell, glucose is acted on by the enzyme glucokinase to
produce glucose-6-phosphate and it undergoes the processes of glycolysis (see Figure 2),
the Kreb's cycle (see Figure 3) and the electron transport chain (see Figure 4) to produce
molecules of the energy compound adenosine triphosphate (ATP) (Inagaki et al., 1992).
The resultant increase in ATP is responsible for closing the ATP-sensitive
potassium channels located on the beta-cell membrane and this leads to the depolarization
(membrane potential is dependent on potassium flux) of the membrane, thus opening the
voltage-gated calcium channels and allowing calcium to enter the cell (Atwater, Dawson,
Eddlestone, & Rojas, 1981). This increase in calcium in the cell induces the release of
more calcium from the intracellular endoplasmic reticulum by activating phospholipase C
which cleaves phosphotidylinositol-4,5-biphosphate (PJP2) into inositol-1,4,5triphosphate (IP3) and diacylglycerol (IP3 binds to a receptor protein in the endoplasmic
reticulum initiating calcium release) (Atwater et al., 1981). The further increase in
calcium causes the release of insulin from the beta-cell by influencing exocytosis (see
Figure 5) (Jewell, Oh, & Thurmond, 2010).
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The newly released insulin binds to insulin receptors on skeletal and cardiac
muscle cells and this action causes the activation of the enzyme tyrosine kinase which
phosphorylates (activates through the donation of a phosphate ion from adenosine
triphosphate breakdown) insulin receptor substrate proteins (Robinson & Buse 2008).
The activated insulin receptor substrate proteins then bind to and subsequently activate
phosphotidylinositol-3 kinase which in turn activates protein kinase B (Robinson & Buse,
2008). Protein kinase B phosphorylates the protein AS 160 (which is responsible for
converting the Rab protein into its inactive form of guanosine diphosphate) and
dissociates it from the glucose transporter protein located inside the muscle cell (GLUT4)
(Hardie, 2002). Once dissociated, AS 160 no longer promotes the Rab-guanosine
diphosphate conversion and the Rab gets converted into its active form, guanosine
triphosphate which causes the translocation of GLUT4 to the cell membrane (Klip &
Paquet, 1999; Hardie, 2002). It should be noted that at all times there are GLUT4s
located on the cell membrane, but the aforementioned process increases the number of
GLUT4s located on the cell membrane (Klip & Paquet, 1999). Extracellular glucose
molecules enter the cell by binding to the membrane spanning GLUT4s (see Figure 6)
(Klip & Paquet, 1999). Once inside the muscle cell, the glucose can be broken down
during glycolysis (see Figure 2), the Kreb's cycle (see Figure 3) and the electron
transport chain (see Figure 4) to produce energy compounds (such as ATP) or it can be
converted into stored energy in the form of glycogen through glycogenesis (see Figure 7).
As glucose progressively enters the muscle cells, blood glucose levels fall
concurrently, with an eventual return to within a normal range (Jewell, Oh, & Thurmond,
2010). This is the end result of the negative feedback system under normal conditions
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(Powers & Howley, 2009). In a pathology such as DM, some of the mechanisms do not
work properly and blood glucose levels do not return to normal unless a form of therapy
is administered (Canadian Diabetes Association, 2008).

1.1.3 DM- A Closer Look: Types, Pathophysiology and Risk Factors
The DM population can be divided into three groups: Those with type 1 diabetes
(T1D; the body lacks insulin), those with type 2 diabetes (T2D; the body is resistant to
insulin) and those with gestational diabetes (GD; affects women during pregnancy) (see
Table 1) (Berg, 1986).
Type 1 DM (T1D)
Pathophysiology of T1D
Although the causes of type 1 DM (T1D) have long been purported to be genetic
and/or environmental another prominent theory in the diabetes literature is that
individuals are insulin-dependent because the beta-cells of the pancreas that produce
insulin are destroyed by the body in an autoimmune attack (Cihakova, 2001).
The trigger and the process for this autoimmune attack are still unknown
(Cihakova, 2001). One theory involves cytotoxic T-cells. Cytotoxic T-cells are
lymphocytes (white blood cells) that destroy viruses, infected cells and cells labeled by
programmed cell death (these cells usually have a bulging or unattached cell membrane)
(Ueda et al., 2003). The cytotoxic T-cells infiltrate the islets of Langerhans (the area
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within the pancreas where the beta-cells are situated) and begin destroying beta-cells
(Ueda et al., 2003).
Whatever the cause, the destruction of beta-cells means that insulin cannot be
produced or secreted by the body. Thus, the negative feedback system fails and
hyperglycemia results (American Heart Association, 2011). As in healthy individuals,
after ingestion of carbohydrates, blood glucose increases in a person with TID (Canadian
Diabetes Association, 2008). Glucose molecules travel through the blood stream and in
healthy individuals, some glucose molecules travel to the pancreatic beta-cells to
stimulate insulin secretion. In contrast, with TID, there are no beta-cells to travel to and
thus no insulin to release (Kloppel, Lhor, Habich, Oberholzer, & Heitz, 1985). Insulin is
responsible for increasing the number of GLUT4s (glucose transporter proteins) on the
muscle cell membrane (Klip & Paquet 1999). Without insulin, the number of GLUT4s
during this state of increased blood glucose concentration remains the same as during the
state of fasting blood glucose concentration (Klip & Paquet, 1999). There are too many
glucose molecules for the GLUT4s to transport into the muscle cell and hyperglycemia
results. The destruction of the beta-cells can progress for many years before it is detected
and this is because symptoms (such as hyperglycemia and ketoacidosis) only develop
when 90% of the cells have been destroyed (Cihakova, 2001).
Risk factors for TID
Individuals with TID may have a genetic predisposition to contracting the
disease. If a female under the age of 25 years with TID gives birth, her child has a 1 in
25 chance of developing TID, but the risk decreases as the age of the birthing mother
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increases (Permutt, Wasson, & Cox 2005). If a man has T1D, then the chances of his
child developing the disease are 1 in 17, but if both parents have T1D then the risk can
increase to 1 in 4 (Permutt et al., 2005). In addition, there are some environmental
factors associated with T1D disease development. It has been noted that T1D develops
more frequently in children who live in places with cold climates and in children who
were exposed to a viral infection (American Diabetes Association, 2009). Also, children
who were not breastfed and began eating solid foods at an earlier age had a greater
chance of developing T1D (Permutt et al., 2005). Even though individuals may differ in
the method of contracting T1D, they all share the commonality of destroyed or decreased
pancreatic beta-cells (Kloppel et al.,1985).
Type 2 DM (T2D)
Type 2 DM (T2D) is also known as adult-onset, insulin-resistant or noninsulindependent diabetes, and accounts for 90-95% of all the documented DM cases
(University of Virginia Health System, 2007; Berg, 1986). T2D is considered adult-onset
because the disease usually affects individuals after the age of 40 years, although there
has been a recent significant increase in the number of children under the age of 16 years
who develop the disease (Berg, 1986; American Diabetes Association 2009). Individuals
are non-insulin dependent because although the body has the beta-cells to produce
insulin, the muscle cells are resistant to it (Weyer, Bogardus, Mott, & Pratley, 1999).
Hyperglycemia results from the delayed glucose uptake by muscle cells on account of the
insulin resistance, and the negative feedback system fails (Weyer et al., 1999). T2D
occurrence depends on genetic predisposition and environmental influence (Canadian
Diabetes Association, 2011).
8

Pathophysiology of T2D
There are four stages in the development of T2D (Weir & Bonner-Weir, 2004).
These stages are insulin resistance, altered beta-cell function, continuous increase of
fasting blood glucose concentration and disease (Weir & Bonner-Weir, 2004). In the first
stage, the beta-cells produce insulin in response to increased blood glucose levels, but the
muscle cells have a reduced ability to take up glucose at that particular blood insulin
concentration (Weir & Bonner-Weir, 2004). The muscle cells' insulin receptors do not
allow any insulin to bind and the GLUT4s are not translocated to the cell membrane to
increase the transport of glucose into the cell (Klip & Paquet, 1999). The beta-cells, in
turn, produce more insulin in an attempt to increase insulin-insulin receptor binding and
promote increased glucose uptake (Weir & Bonner-Weir, 2004). This increase in insulin
production causes the beta-cells to increase in number and size (Weir & Bonner-Weir,
2004). In some individuals, the beta-cells cannot produce the amount of insulin needed
for adequate insulin-insulin receptor binding and adequate glucose uptake, and
hyperglycemia results (Weir & Bonner-Weir, 2004).
The phenomenon of insulin resistance and its causes are still not fully understood.
It is unknown why the muscle cells become resistant to the insulin that is secreted to
increase glucose uptake. There are, however, some common characteristics among
individuals with insulin resistance such as abdominal obesity (a waist circumference of
greater than 102 cm and 88 cm in men and women, respectively), dyslipidemia (an
abnormal lipid profile of hypertriglyceridemia (increased triglyceride levels of >1.7 mM),
high low-density lipoprotein (LDL) (>3.4 mM) and a low level of high-density
lipoprotein (HDL) (<1.0 mM and <1.3 mM in men and women, respectively)),
9

hypertension (sustained elevations in resting arterial blood pressure; BP) and increased
fasting blood glucose concentration. Although the causes of insulin resistance are
unknown, a potential long term outcome is T2D. (Canadian Diabetes Association, 2008)
The second stage of T2D development is altered beta-cell function. With insulin
resistance and decreased glucose uptake, an individual's fasting blood glucose level
increases from the normal ~4.0 mM to >5.6 mM (Brunzell et al., 1976). As fasting blood
glucose levels approach 5.6 mM, beta-cells begin to secrete less insulin (Brunzell et al.,
1976). Combined with insulin resistance, this decrease in insulin secretion contributes to
hyperglycemia because less insulin is available to help promote glucose uptake (Weir &
Bonner-Weir, 2004). Eventually the fasting blood glucose levels are increased beyond
6.7 mM, a level at which insulin secretion almost completely ceases (Brunzell et al.,
1976). The molecular mechanisms behind the loss of insulin secretion are unknown, but
glucose toxicity offers a potential explanation (Brunzell et al., 1976). Beta-cells function
in an optimal range of blood glucose concentration (4.0 mM-6.0 mM) and if the blood
glucose levels increase too high (>6.7 mM), the constant internal environment changes
and the functions of the beta-cells begin to alter and almost cease (Brunzell et al., 1976).
Altered beta-cell function and loss of insulin secretion lead to even less glucose uptake
and a greater degree of hyperglycemia (Weir & Bonner-Weir, 2004).
In the third stage of T2D development, the fasting blood glucose levels continue
to rise above 7.4 mM due to the insulin resistance of muscle cells and the impaired
insulin secretion of the pancreatic beta-cells. From stage three, it can take an individual
several years before they reach stage four, fully developed T2D. In stage four, the body
produces just enough insulin to allow muscle cells to take up some glucose and combat
10

ketoacidosis (decrease in arterial pH due to the presence of excessive ketones from fat
metabolism in lieu glucose metabolism) (Weir & Bonner-Weir, 2004)
Risk factors for T2D
Environmental factors have a significant influence on T2D development
(American Diabetes Association, 2004). Individuals who are obese or who lead the
"Western" lifestyle (calorie-rich diet, high-fat diet and low physical activity) are at risk
for T2D, especially if they have a family history of the disease (Malecki, 2005). If one
parent has been diagnosed with T2D before the age of 50 years, then the child has a 1 in 7
chance of developing T2D, but the risk does decrease as the parent's age of onset
increases (Malecki, 2005). If both parents have been diagnosed with T2D at any age,
then the child has a 1 in 2 chance of developing T2D (Malecki, 2005).
Gestational Diabetes (GD)
Gestational diabetes (GD) affects approximately 4% of all pregnant women, and
represents new-onset hyperglycemia and T2D during pregnancy (Canadian Diabetes
Association, 2009; Campbell et al., 2009). Women who are above the age of 35 and/or
are obese have an increased risk of developing GD (Canadian Diabetes Association,
2009). Also women who have had GD in the past or have given birth to overgrown
babies increase their chances of developing the condition (Canadian Diabetes
Association, 2009). If an affected woman does not control her GD, not only does she
increase her risk of developing T2D later in life (Canadian Diabetes Association, 2009),
she increases nutrient availability to her fetus which contributes to fetal overgrowth and
adiposity (Catalano,Kirwan, Haugel-de Mouzon, & King, 2003).
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Pathophysiology and risk factors for GD
Much like T2D, the exact cause of GD is unknown, but insulin resistance (see
Pathophysiology of type 2 diabetes) is an integral part of the condition (Catalano et al.,
2003). Another potential cause of GD is abnormal beta-cell sensing of glucose (Catalano
et al., 2003). On the pancreatic beta-cell, the glucose sensor and transporter is GLUT2
(Inagaki et al., 1992) and by means unknown, GLUT2 functions become impaired and
beta-cell does not take up glucose or release insulin and the outcome is hyperglycemia
(Inagaki et al., 1992; Catalano et al., 2003).

1.1.4 Complications of DM
DM has many associated complications, some of which are specific to the form of
DM, and some of which are common among all three types (Canadian Diabetes
Association, 2008). One of the most common complications of TID and a leading cause
of hospitalizations is ketoacidosis, which occurs if an individual fails to administer a
sufficient amount of insulin (Berg, 1986). Complications that are common among
individuals with DM regardless of the type are neuropathy (nerve disease), nephropathy
(kidney disease), endothelial dysfunction and hypertension (high systemic arterial blood
pressure) (Canadian Diabetes Association, 2008). No matter the type of complication,
the side effects can be very serious and even deadly (Canadian Diabetes Association,
2008).
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Ketoacidosis
Ketoacidosis is a condition which affects individuals with T1D, although there
have been rare cases of individuals with T2D with the condition (Berg, 1986). With
inadequate administration of exogenous insulin (a common treatment for T ID discussed
below in the section titled Pharmacological Treatment Options for DM), glucose cannot
be used to produce the energy compounds needed to fuel the body. To review, insulin
increases the number of glucose transporters (GLUT4s) on the muscle cell membrane that
are responsible for glucose entry into the cell (Klip & Paquet, 1999). Without insulin, the
increase in GLUT4s does not occur (Klip & Paquet, 1999) and inadequate glucose is
transported into the cell therefore, the body needs to rely on another source to create
energy compounds (such as ATP) that will be use in bodily processes. The alternative
energy sources are ketone bodies (Fery & Balasse, 1985).
Ketone bodies are created in the liver and are used as a source of fuel when the
muscle cells are unable to use glucose in glycolysis and the Kreb's cycle for fuel (Fery &
Balasse, 1985). Specifically, the liver acquires acetyl coenzyme A (acCoA) from the
oxidation of fatty acids and two molecules of acCoA are acted upon by the enzyme
thiolase to form acetoacetyl coenzyme A which is eventually converted into the ketone
body acetoacetate (Hird & Symons, 1962). Acetoacetate can enter the blood stream as
itself, but it can also undergo reactions to form two other ketone bodies called betahydroxybutyarate and acetone (Lopes-Carodoso et al., 1975). All three ketones enter the
blood stream, acetone travels to the kidneys to be expelled in urine and the former two
travel to the muscle cell (Hird & Symons, 1962). Inside the muscle cell, the ketone
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bodies are converted into acCoA to be used in the Kreb's cycle to produce ATP, depicted
in Figure 8.
If the ketone bodies are produced faster than they are catabolized or taken up by
the muscle cells, they begin to accumulate in the blood stream (to bring the blood pH
below 7.2) and ketoacidosis occurs (Fery & Balasse, 1985). An individual with
ketoacidosis may feel thirsty and/or nauseous, have abdominal pain, display frequent
urination and have acetone breath (sweet, fruit-like smelling breath) (Chiasson et al.,
2003). Ketone bodies are strong acids and their accumulation can disrupt any
physiological function ultimately leading to death if untreated (Chiasson et al., 2003).
Ketoacidosis can be treated with intravenous insulin administration (Chiasson et al.,
2003).
Neuropathy
Neuropathy is a disorder arising from nerve damage (Canadian Diabetes
Association, 2008). There are four types of diabetic neuropathies: peripheral (affects
legs, feet, toes, arms, hands and fingers), autonomic (affects heart rate, blood pressure,
perspiration, and digestive, bowel, bladder and sexual function), proximal (affects thighs,
hips and buttocks) and focal (affects a single nerve or group of nerves causing localized
muscle weakness) (National Institute of Diabetes and Digestive and Kidney Diseases,
2009). Peripheral neuropathy is the most common type of neuropathy in DM and the
popular sites of nerve damage are the ulnar, peroneal (fibular) and tibial nerves which
lead to loss of sensation and uncomfortable pain in the wrists and feet (Dyck & Thomas,
1999; National Institute of Neurological Disorders and Stroke, 2008). Neuropathy takes
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several years to develop and it is a condition with many pathologies and etiologies
(Vinik, Strotmeyer, Nakave, & Patel, 2008). With respect to the diabetic population, it is
believed that neuropathy is caused by hyperglycemia and dyslipidemia (Vinik et al.,
2008). Hyperglycemia and dyslipidemia cause peripheral arterial disease (PAD), which
itself is a complication of DM (and will be discussed below in Peripheral Arterial
Disease (PAD)), but one which reduces blood flow and increases hypoxia (lack of
oxygen) to the nerves causing damage (Vinik et al., 2008). There is no true treatment for
neuropathy, but affected individuals can wear properly fitted shoes and take analgesics to
reduce pain (National Institute of Neurological Disorders and Stroke, 2008).
Nephropathy
Nephropathy is the term used to describe kidney disease (Canadian Diabetes
Association, 2008). Kidney disease describes a collection of pathologies that prevent the
kidney from performing its filtering and blood pressure regulation functions causing
wastes and excess fluids to remain in the body (The Kidney Foundation of Canada,
2009c). Almost half of all individuals with nephropathy also have DM (Canadian
Diabetes Association, 2008). Although kidney disease has many causes,
glomerulosclerosis (thickening of the tiny blood vessel walls of the kidney) is the most
common cause in DM (Kalant, 1978). In a normal kidney, blood filtering occurs in the
glomerulus (a collection of capillaries) where blood pressure (BP) forces water and small
molecules out of the capillaries, into the nephron tubule and out of the kidneys as urine,
leaving larger and much needed molecules such as red blood cells and protein to continue
circulating throughout the blood (Campbell et al., 2009). Glomerulosclerosis causes
damage to the blood vessel walls and allows for the large proteins to be forced out of the
15

capillaries and into the nephron and it compromises waste filtering (Kalant, 1978).
Along with compromised waste filtering, there is poor resting arterial BP regulation
because the kidney damage creates a situation where excess water that is to be expelled
as urine re-enters blood circulation (Kalant, 1978). The first indication of kidney disease
is proteinuria (excess protein in the urine >30mg/day) (Canadian Diabetes Association,
2008). The damage and thickening of the vessel walls in the glomerulosclerotic
condition is associated with hyperglycemia (Kalant, 1978). The increase in vessel wall
thickening is proportionate to increases in blood glucose concentration (Kalant 1978).
Treatment options for kidney disease include dialysis and transplantation. With
dialysis, a machine withdraws blood from the body and passes it through a dialyzer (an
artificial kidney) (The Kidney Foundation of Canada, 2009a). The dialyzer contains
dialysis fluid that is responsible for removing waste products from the blood (The Kidney
Foundation of Canada, 2009a). A day dialysis treatment session can take up to 5 hours
and most individuals receive 3 treatments per week (The Kidney Foundation of Canada,
2009a). Nocturnal dialysis treatments (offered separately from day dialysis treatments)
take place while the individual is asleep and there are usually 6-7 treatment sessions each
week (Pierratos, 1999). The second treatment option for kidney disease is
transplantation. Transplantation involves removing affected kidneys and replacing them
with healthy kidneys from either a live or recently deceased donor. Kidney transplants
have a success rate of 85-95% (The Kidney Foundation of Canada, 2009b).
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Endothelial Dysfunction
In DM, it is thought that hyperglycemia and dyslipidemia contribute to the
dysfunction of the vascular endothelium (Canadian Diabetes Association, 2008). The
endothelium is a type of simple squamous epithelium that lines the heart and blood
vessels. The endothelium functions to regulate vascular tone (the degree to which a
blood vessel is vasoconstricted or vasodilated), control thrombogenic processes (prevent
the formation of blood clots and influence the degradation of them) and control
inflammatory processes (such as platelet adhesion to blood vessel walls) (Ehrman,
Gordon, Visich, & Keteyian, 2009). In a healthy endothelial cell, nitric oxide is produced
and transported into vascular smooth muscle cells (VSMC) where it acts as the prominent
agent for vasodilation, depicted in Figure 9. The process of nitric oxide formation begins
with a receptor located on the endothelial cell membrane (Boger et al., 1998). The
receptor is coupled with acetylcholine, bradykinin or acted upon by shear stress (from
increased blood flow) and this stimulates an increase of calcium in the cytosolic space
(Hayden & Tyagi, 2002). The increase in calcium activates the enzyme nitric oxide
synthase (eNOS) which reacts with oxygen and this action allows for the co-factor
tetrahydrobiopterin to couple another co-factor, nicotinamide adenine dinucleotide, to Larginine to form nitric oxide and L-citruilline (see Figure 10) (Boger et al., 1998). The
effects of nitric oxide are counterbalanced by the production and release of
vasoconstricting substances, the most powerful one of which is endothelin 1 (ET-I)
(Morris & Jardine, 2000). ET-I acts on VSMC to induce vasoconstriction via endothelin
A receptor activation. In contrast, it also acts as a negative feedback mechanism by
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stimulating endothelin B receptors and triggering the release of nitric oxide (Morris &
Jardine, 2000).
Endothelial dysfunction occurs when there are alterations in the expression and/or
release of vasoactive, anti-growth, anti-inflammatory and/or anti-thrombotic substances
(Faulx, Wright, & Hoit, 2003), thus preventing the endothelium from properly carrying
out its function (Avogaro, Fadini, Gallo, Pagnin & de Kreutzenberg, 2006). In DM and
other cardiovascular diseases, endothelial dysfunction is believed to occur as a result of
reduced nitric oxide bioavailability, increased reactive oxygen species (ROS; highly
reactive oxygen ions that can damage cell structures) and/or atherogenesis (formation of
fatty deposits on the inner lining of the arteries) (Ding & Triggle, 2005). With respect to
the former, potential causes of reduced bioavailability include 1) reduced L-arginine
concentrations, 2) the down-regulation of eNOS, 3) impaired eNOS activation, and 4)
increased oxidative stress/ROS-induced nitric oxide degradation (discussed below)
(Faulx et al., 2003).
In addition, hyperglycemia and dyslipidemia cause an increase in protein arginine
N-methyltransferase activity (Nash, 2002). Protein arginine N-methyltransferase is the
enzyme responsible for the formation of assymetrical dimethylarginine (ADMA).
ADMA is an inhibitor of L-arginine (Nash, 2002). With L-arginine deficiency, the
nicotinaminde adenine dinucleotide reacts with oxygen instead of the L-arginine and a
superoxide, instead of nitric oxide, is produced (Hayden & Tyagi, 2002). This form of
dysfunction has the endothelial cell producing less nitric oxide and in turn decreases
vasodilation and blood flow, and increases vasoconstriction and blood pressure (Boger et
al., 1998). Also, the formation of superoxides instead of nitric oxide is detrimental to all
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cells because superoxides react with transition metals (i.e., iron) to form hydrogen
peroxide and then a hydroxyl radical, or they react with nitric oxide (formed in a separate
cell) to form peroxynitrite (see Figure 11) (Beckman & Koppenol, 1996; Turrens, 2003).
The hydroxyl radical and peroxynitrite are known as (ROS) and they react with nucleic
acids and proteins altering their functions and contributing to endothelial dysfunction
(Beckman & Koppenol, 1996).
Endothelial dysfunction can also be caused by diabetic dyslipidemia itself.
Diabetic dyslipidemia increases the risk of developing atherosclerosis (fatty deposits on
the inner lining of the arteries) by three-fold (Kannel & McGee, 1979). In the diabetic
dyslipidemic condition, readily available and over abundant LDLs are taken up by the
endothelial cells where they are acted upon by ROS and the enzymes sphingomyelinase,
secretory phospholipase and myeloperoxidase to create oxidized LDLs which are proinflammatory lipids that attract certain monocytes (white blood cells) called macrophages
(Rose & Afanasyeva, 2003; Rader & Daugherty, 2008). The macrophages take in
oxidized LDLs through the scavenger receptors CD36 and SR-A to form lipid-laden foam
cells (see Figure 12) (Rader & Daugherty, 2008). The foam cells migrate to the
endothelial wall where they create a pro-inflammatory environment by producing
cytokines that signal intimal (endothelial lining of the blood vessel or lumen)
proliferation and the production of myeloperoxidase, an enzyme that produces ROS,
which leads to more foam cell production and further endothelial damage (as ROS
disrupt nucleic acids and proteins) (Rader & Daugherty, 2008). The foam cells also
collect cholesterol and platelets, and can develop into a lesion or plaque that narrows the
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lumen and contributes to endothelial dysfunction, hypertension and/or reduced blood
flow (Rader & Daughtery, 2008).
Endothelial cell damage and the resultant dysfunction is thought to be a major
contributor to the development and progression of cardiovascular disease (Ehrman et al.,
2009). The term cardiovascular disease encompasses several disease states that affect the
heart or blood vessels, such as coronary artery disease (including atherosclerosis
(thickening of arterial walls due to fatty deposits), angina and myocardial infarction),
hypertension, PAD (including atherosclerosis), rheumatic heart disease (damage to the
heart muscle and heart valves caused by bacteria), congenital heart disease
(malformations of the heart present at birth) and heart failure (World Health
Organization, 2009b). The first, coronary artery disease is often used interchangeably
with the term cardiovascular disease and/or atherosclerosis, as not only is it the most
prominent form of cardiovascular disease, atherosclerosis predominantly occurs in the
coronary arteries (World Health Organization, 2009b). When the atherosclerosis occurs
in the arteries leading to the brain it is referred to as either carotid artery disease or
cerebrovascular disease, depending on the location of the atherosclerosis, and finally as
PAD when referring to the arteries outside of the heart and brain (American Heart
Association, 2008b). Atherosclerosis is the leading cause of cardiovascular disease
(Canadian Diabetes Association, 2008).
Hypertension
Hypertension, characterized by a sustained elevation in resting BP that is equal to
or above 140 mmHg(systolic) and/or 90 (diastolic) mmHg, affects most individuals with
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diabetes (Canadian Diabetes Association, 2008). Systolic BP represents the pressure
acting against the arterial walls as blood is ejected from the heart and its contracting
ventricles, while diastolic BP represents the pressure acting against arterial walls when
the heart's ventricles are relaxing and filling with blood (Powers & Howley, 2009). As
previously discussed, one cause of hypertension in diabetics is the loss of regular kidney
function which regulates BP (Kalant, 1978). As BP is dependent on volume, the
accumulated, excess water re-enters the circulation and increases BP (Kalant, 1978). The
pressure increase also influences the progression of kidney disease because it causes
more force to be exerted on blood vessel walls which contributes to their damage (Kalant,
1978). When the blood vessels of the kidneys are damaged, the kidneys cannot function
properly and their pathology progresses at a faster rate (Kalant, 1978).
Resting BP is also dependent on vascular resistance (resistance to blood flow
provided by blood vessels). In the diabetic condition, increased vasoconstriction is
caused by increased levels of the enzyme protein kinase C due to hyperglycemia (Koya &
King, 1998). An individual with hyperglycemia will still exhibit glucose uptake by cells
using the glucose transporter proteins (Klip & Paquet, 1999), yet it is not sufficient
enough to reduce blood glucose levels. It is, however, sufficient enough to increase
levels of protein kinase C (Koya & King, 1998). Glucose enters the cell and is converted
into dihydroxyacetone phosphate (DHAP) via glycolysis (Koya & King, 1998). DHAP is
acted on by the enzyme glycerol-3-phospate dehydrogenase to form glycerol-3-phosphate
(Koya & King, 1998). Glycerol-3-phophate goes through a series of reactions to form
diacylglycerol (see Figure 13) (Yoshimura, Oshima, & Ogasawara, 2007). After 3-5 days
of hyperglycemia, there is a noticeable and significant increase in diacylglycerol
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concentration (Koya & King, 1998). Diacylglycerol activates protein kinase C which is
responsible for increased calcium responsiveness in smooth muscle contraction
(vasoconstriction) (see Figure 14) and increased smooth muscle contraction itself (Koya
& King, 1998).
Another probable cause of increased vascular resistance in the diabetic condition
is smooth muscle cell proliferation due to increased mitogen-activated protein kinase
(MAPK) activation (Bruemmer, 2006). Hyperinsulinemia (in T2D) causes increased
MAPK activity (Bruemmer, 2006). In the healthy condition, insulin binds to the insulin
receptor on the cell membrane and the phophotidylinositol-3 kinase (see Negative
Feedback and Blood Glucose Regulation Mechanisms) pathway is activated (Robinson
& Buse, 2008). In an individual with T2D, the phophotidylinositol-3 kinase pathway is
inhibited and instead the MAPK pathway is activated (see Figure 15) (Bruemmer, 2006).
The insulin binds to the insulin receptor and this action causes the activation of the
enzyme tyrosine kinase which phosphorylates insulin receptor substrate proteins
(Robinson & Buse, 2008). The activated insulin receptor substrate proteins then bind to
the Src homology 2 protein and the two proteins interact with another protein (growth
factor receptor bound protein 2) and all three proteins bind to the Ras guanylnucleotide
exchange factor son of sevenless to create a protein complex (Kusari, Byon,
Bandyopadhyay, Kenner, & Kusari, 1997). The activated protein complex removes
guanosine diphosphate from Ras, after which Ras binds to guanosine triphosphate and
becomes activated (Kusari et al., 1997). Activated Ras activates Raf protein kinase
which activates mitogen-activated protein kinase kinase, after which MAPK is then
activated (Kusari et al., 1997). MAPK is responsible for smooth muscle cell
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proliferation (Bruemmer, 2006). Increased smooth muscle cell mass increases vascular
resistance because more cells are available to induce vasoconstriction (Koya & King,
1998).
The adoption of a healthy lifestyle, including weight loss strategies, sodium
restriction and regular physical activity, is an integral component of hypertension
treatment and management in DM. A decrease of 1 kilogram in body weight has been
proven to decrease mean BP (calculated as [resting diastolic BP + 0.33 x (systolic BPdiastolic BP)]) by 1 mmHg. Furthermore, reductions in dietary sodium intake to less than
2300 mg per day is associated with systolic BP and diastolic BP reductions of 5 mmHg
and 3 mmHg, respectively. (American Diabetes Association, 2002)
For many individuals, pharmacological therapy is required in addition to lifestyle
modifications to reduce resting BP to values within the target range. Drug therapy for
individuals with DM and hypertension includes a combination of angiotensin converting
enzyme (ACE) inhibitors, beta-blockers, calcium channel blockers and diuretics.
(Canadian Diabetes Association, 2008)

1.1.5 Recommendations for the Treatment of DM
Exercise
Exercise training is a non-pharmacological, non-surgical treatment recommended
for DM (American College of Sports Medicine, 2010). Exercise, and thus the
components of an exercise training program, can be aerobic or anaerobic in nature.
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Exercise is considered aerobic when performed at <70% of maximum heart rate
(Conners, Grymkowski, Kimber, & Reynolds, 1992). Aerobic exercise uses both
carbohydrates and fats as a fuel source (Powers & Howley, 2009), and ATP is created via
the Kreb's cycle (see Figure 3) and the electron transport system (see Figure 4).
In general, anerobic exercise is performed at an intensity of >75% of an
individual's maximum heart rate (Conners et al., 1992), and ATP is produced from
glycolysis (see Figure 2) and the phosphagen energy system (see Figure 16) in the
absence of oxygen (Conners et al., 1992). Although resistance exercise is classified as a
type of anaerobic exercise, it applies a force of resistance against the force of contraction
(Conner et al., 1992), and is, as such, not driven by maximal heart rate. There are three
different types of resistance exercises: concentric (shortening of muscle fibers due to
greater muscle force than resistance force), eccentric (lengthening of muscle fibers due to
greater resistance force than muscle force) and isometric (no change in fiber length due to
the resistance force and muscle force equaling one another) (Heyward, 2006; Hamill &
Knutzen, 2003). Isometric exercise is often distinguished separately from concentric and
eccentric resistance exercise because of its unique resistance force and lack of fiber
length change.
In general, both aerobic and anaerobic exercise training regimens have shown to
improve tissue insulin sensitivity (how well muscle cells respond to insulin) in those with
DM (Winnick et al., 2008; Jimenez, Santiago, Sitler, Boden, & Homko, 2009).
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Improved insulin sensitivity
Although T1D is characterized by insulin inavailability, sensitivity to existing
insulin is increased with chronic, but not acute, exercise exposure in this population. For
example, Jimenez and colleagues (2009) saw no change in pre- to post-exercise insulin
sensitivity in adults with T1D (n=14) who performed 5 sets of 6 repetitions of a
resistance leg exercise at 80% of 1 repetition maximum (Jimenez et al., 2009). In
contrast, 12 weeks of aerobic exercise training (3 times per week for 45 minutes) at 8075% maximum heart rate intensity increased insulin sensitivity by 25+/- 5% in children
(n=15) with T1D (Landt, Campaigne, James, & Sperling, 1985).
Individuals with T2D have a lower insulin sensitivity than their T1D counterparts
(Weir & Bonner-Weir, 2004) and their reaction to exercise differs as well. The positive
effect of exercise on insulin sensitivity in T2D is noticeable after both acute and chronic
exercise. In a population of T2D (n=9), a single bout of exercise performed for 15
minutes at anaerobic threshold intensity can increase glucose infusion rate (an index of
insulin sensitivity) by 3.2+/-0.8 mg/kg/min (Oguri, Adachi, Ohno, Oshima, &
Kurabayashi, 2009) immediately post-exercise. These findings were further supported by
Winnick and colleagues (2008) who observed increases in whole-body insulin sensitivity
after one week of exercise. Specifically, 18 obese T2D individuals performed 50 minutes
of treadmill aerobic walking (at 70% of maximal oxygen uptake) everyday for 7 days,
and post-training increases in glucose infusion rates of 0.2+/- 0.3 mm/kg/min were noted
(Winnick et al., 2008).
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The exercise data on GD and insulin sensitivity and resistance are limited and
equivocal. With respect to the effect of acute exercise, a study conducted by GarciaPatterson and colleagues (2006) examining 20 non-exercise trained women with GD who
performed a self-paced flat surface walking bout for 1 hour found decreases (0.7+/- 0.9
mM) in 1 hour postprandial blood glucose, when the women served as their own controls
the day prior (Garcia-Patterson et al., 2006). A second study (n=33) comparing women
with GD who exercise trained (30 minutes, 4 days per week, 12 weeks, 70% maximal
oxygen uptake) to those who were sedentary observed no differences in insulin
sensitivity, insulin resistance or blood glucose concentration between the two groups
(Avery, Leon, & Kopher, 1997). The authors did, however, report modest, but not
statistically significant, increases in cardiovascular fitness.
Aerobic and anaerobic (including resistance) exercise not only increases insulin
sensitivity and improves insulin resistance in T1D, T2D and GD, evidence suggests that
individuals with T2D will exhibit improvements in GLUT4-driven glucose regulation
with exercise (Kennedy et al., 1999).
Improved blood glucose regulation in T2D: GLUT4s and their translocation
As previously discussed, glucose transporter proteins (GLUT4s) are needed for
the uptake of glucose by the muscle cells (Klip & Paquet, 1999). GLUT4 translocation
can be insulin-stimulated, but it can also be contraction (or exercise) stimulated (Hardie,
2002). Acute aerobic exercise (one session of cycling at 60-70% maximal oxygen uptake
for 45-60 minutes) performed by adults with T2D elicited a 77% increase in membrane
GLUT4 when compared to the resting condition (Kennedy et al., 1999).
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Exercise-induced increases in GLUT4 have also been noted in individuals with
T2D following resistance exercise training. Holten and colleagues (2004) examined 10
individuals with T2D who served as their own control for a resistance exercise study.
Participants completed 3 different unilateral leg exercises (3 sets, 8-12 repetitions at 7080% of 3 repetition maximum), 3 times per week for 6 weeks (Holten et al., 2004). After
the intervention, GLUT4 density was increased by approximately 40% in the trained legs
when compared to the untrained (control) legs (Holten et al., 2004). The trained legs also
displayed an increase in thigh circumference (52.5+/-1.5 cm to 54.3+/-1.9 cm) and
muscle fiber diameter (5.4+/-1.7%) (Holten et al., 2004).
The contraction-stimulated GLUT4 translocation mechanism follows a different
pathway than that of the insulin-stimulated GLUT4 translocation (Kruth-Kraczek,
Hirshman, Goodyear, & Windder, 1999). The insulin-stimulated pathway involves the
insulin receptor and protein kinase B, while the contraction-stimulated pathway involves
adenosine monophosphate-activated protein kinase (AMPK) (Robinson & Buse, 2008;
Kruth-Kraczek et al., 1999).
Exercise (aerobic and anaerobic) causes a change in the cellular energy status
recognized by an increase in adenosine monophosphate concentration due to the
breakdown of the fuel adenosine triphosphate (Kruth-Kraczek et al., 1999). The increase
in adenosine monophosphate activates AMPK B which phosphorylates the protein
AS 160, which is responsible for converting the Rab protein into its inactive form of
guanosine diphosphate and inhibiting GLUT4 movement, and dissociates it from GLUT4
located inside the muscle cell (Hardie, 2002). Once dissociated, AS 160 no longer
promotes the Rab-guanosine diphosphate conversion and the Rab gets converted into its
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active form, guanosine triphosphate which causes the translocation GLUT4 to the cell
membrane (see Figure 17) (Klip & Paquet, 1999; Hardie, 2002). Although the activating
mechanisms for GLUT4 translocation differ between insulin-stimulated and contractionstimulated situations, both pathways dissociate AS 160 from GLUT4 allowing it to be
transported to the membrane (Hardie, 2002; Klip & Paquet, 1999). The increase in
GLUT4s increases glucose uptake by the muscle cells and this reduces the elevated blood
glucose concentration in T2D reducing the extent of hyperglycemia and its effects
(decreased nitric oxide production and increased ROS production) (Klip & Paquet 1999).
Exercise Recommendations
In light of the above-described benefits of exercise in those with DM, exercise is a
highly recommended treatment option, particularly for those with T2D. The gold
standard exercise prescription guidelines, endorsed by the American College of Sports
Medicine, recommend 20 to 60 minutes (which can be divided into 10 minute bouts for a
total of 150 minutes per week) of dynamic aerobic activity at 50-75% of maximum heart
rate, 3 to 7 times per week, supplemented with light weight training 2 to 4 days per week.
The aerobic activity can include walking, running, swimming or cycling, for example,
and light weight training refers to resistance training focusing on larger muscle groups
with weights ranging between 60-80% of 1 repetition maximum for at least 2 sets of 8-12
repetitions. (American College of Sports Medicine, 2010)
Pharmacological Treatment Options for DM
Those with T1D require exogenous insulin daily to control blood glucose
concentration (Berg, 1986). This exogenous insulin is synthetically engineered and
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produced, and can be injected into the body using a syringe (a needle and vial system), an
insulin pen (pre-filled with insulin and dosage-controlled via a dial) or an insulin pump
(delivers short-acting insulin throughout the day using a catheter placed under the skin)
(Canadian Diabetes Association, 2008).
Individuals with T2D can treat or control their decreased insulin sensitivity with
the use of oral medications. Thiazolidinediones and biguanides increase the body's
insulin sensitivity. Sulfonylureas and meglitinides stimulate the pancreas to synthesize
more insulin. These drugs, in turn, help lower blood glucose, and some can be combined
to elicit a greater response, but the risk of side effects increases with their combination
(Canadian Diabetes Association, 2008).
Expectant mothers with GD, when necessary, can be prescribed insulin for
injection without harming the fetus (Canadian Diabetes Association, 2009).

1.2 Peripheral Arterial Disease in DM
1.2.1 Peripheral Arterial Disease (PAD)
As previously discussed, peripheral arterial disease (PAD) is a common
complication of DM and is characterized by structural changes (such as inflammation or
tissue damage) in the blood vessels outside of the heart and brain, and these changes
cause reduced blood flow to the tissues (American Heart Association, 2009b). The most
common symptom of PAD is intermittent claudication which is described as pain or
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cramping in the muscles of the lower extremities brought on by walking and relieved by
rest, yet some diabetics are asymptomatic due to their neuropathy-induced loss of
sensation (American Diabetes Association, 2003). PAD affects individuals with DM
mainly in the popliteal and tibial arteries (below the knee) (American Diabetes
Association, 2003). DM-associated hyperglycemia and dyslipidemia are two main causes
of PAD (American Diabetes Association, 2003). PAD is also an underlying cause of
other diabetic conditions such as neuropathy and nephropathy (Kalant, 1978; Vinik et al.,
2008).

1.2.2 Methods of Assessing PAD
There are many ways to measure and assess PAD, including the most widely
employed methods of angiography, ankle-brachial index and duplex ultrasound.
Catheter angiography, also known as conventional angiography, is a minimally
invasive test and the gold standard for PAD assessments (Radiological Society of North
America, 2010; Clifton, 2000). A catheter containing a contrast dye is inserted into an
artery through an incision in the skin after which the artery undergoes an x-ray
(Radiological Society of North America, 2010; Clifton, 2000). Catheter angiography is
the most accurate form of PAD assessment; however, it is associated with several risks
such as infections and kidney damage (Radiological Society of North America, 2010).
Phased-contrast magnetic resonance angiography non-invasively assesses PAD.
Various magnetic fields are applied to the limb or body part in question. Several images
are acquired and a mathematical pixel by pixel calculation is applied to phase out static
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tissues (muscle and bone) leaving only the flowing blood visible on the final image.
Similar to catheter angiography the final image can be used to detect arterial narrowings
and malformations, but unlike the gold standard method, phased-contrast angiography
can also measure blood flow. However, this method of assessment is time consuming
and adversely affected by slight movements made by the individual undergoing the
angiography. (Clifton, 2000)
The ankle-brachial index (ABI) is another non-invasive test used to assess PAD,
and involves the measurement of ankle systolic BP (using dorsalis pedis and posterior
tibial arteries) and arm systolic BP (using the brachial artery) to ultimately evaluate the
patency of the arteries of the lower extremities (Bernstein & Fronek, 1982). Specifically,
a ratio (ABI) between the ankle and arm is determined from the measured systolic BPs
(e.g., ankle systolic BP/ brachial artery BP) (Bernstein & Fronek, 1982). For the
calculation, the greater value of the two brachial pressures is used, and both ankle
pressures (on each leg) are used to give a total of 4 ABIs per individual (Bernstein &
Fronek, 1982). A normal, non-diseased lower extremity artery will have an ABI >0.90
while a diseased artery will have an ABI of <0.90 (Carbayo et al., 2007). To further
classify PAD, an ABI of 0.70-0.89 suggests a mild obstruction in the artery, 0.40-0.69
suggests a moderate obstruction, and <0.40 suggests a severe obstruction (American
Diabetes Association, 2004d). The ABI test has been validated against angiographically
confirmed disease (accuracy range: 95-100%) (Bernstein & Fronek, 1982). One
limitation of the ABI is the influence of poorly compressible and calcified vessels. In
such instances, BP measurements cannot be obtained as a result of the arteries' inability
to occlude, leading to artefactually elevated ABIs of >1.30 (Bernstein & Fronek, 1982).
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Another limitation is that aortoiliac stenoses (abnormal narrowing of the aorta or iliac
arteries) can reduce BP in the lower extremity (and in turn reduce the ABI) causing the
false belief that the PAD is solely in the lower extremity (American Diabetes
Association, 2004). Even with these limitations, ABI is a highly used, popular and
proven non-invasive method of PAD assessment in clinical settings (American Diabetes
Association, 2004).
Another method of assessing PAD is duplex ultrasound which uses a combination
of two techniques to obtain arterial images and determine the degree of the disease
(Scottish Intercollegiate Guidelines Network, 2006). Images are acquired through both
B-mode ultrasound (using sound frequencies to produce an arterial image) and Doppler
ultrasound (using reflected sound waves to generate an image of blood flow direction and
velocity) and assessed together (Scottish Intercollegiate Guidelines Network, 2006). Bmode ultrasound provides a visual image of arterial narrowings, while Doppler
ultrasound uses blood flow and velocity to determine the amount (in percent) of
anatomical narrowing (Sensier et al., 1996). Duplex ultrasound has been proven to 9299% accuracy when compared to angiography (Aly et al., 1998).
In addition to the assessment of PAD itself, the symptoms of the disease can be
evaluated. A common practice is the assessment of intermittent claudication using a
graded-exercise treadmill test (Gardner, Skinner, Cantwell, & Smith, 1999). There are
different protocols for the graded-treadmill test, a popular one of which is the Gardner
protocol (Gardner et al., 1999). Using the Gardner protocol, individuals walk on the
treadmill at a constant 2 mph, beginning at 0% grade, with a 2% increase in grade every 2
minutes to a maximum of 14 % (completing the 2 minutes at 14% for a maximum total of
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16 minutes on the treadmill) (Gardner et al., 1999). During the graded-exercise treadmill
test, the distance at which the individual first notices claudication pain is recorded and
this is referred to as the initial claudication distance (ICD) (Hiatt, Nawaz, Regensteiner,
& Hossack, 1998). The absolute claudication distance (ACD), the distance at which the
individual reaches maximal claudication pain causing the termination of the test, is also
recorded (Hiatt et al., 1998). The graded-exercise treadmill test is used clinically across
all age groups and disease states and has a within-subject variation of 15-25% for the
ICD and 12-13% for the ACD (Hiatt et al., 1998). This test is superior to the previously
popular constant-load treadmill test, where individuals walk at 2 mph at a constant grade
of any value between 0% and 12% for a maximum of 5 minutes, which has a withinsubjects variation of 30% for the ICD and 45% for the ACD (Gardner et al., 1999).
Increases in ICD and ACD with repeated graded-exercise treadmill tests correlate with
improved ambulatory function (Hiatt, Regensteiner, Hargarten, Wolfel, & Brass, 1990).

1.2.3 Treatment recommendations for PAD
The most effective treatment and control methods for PAD are of the surgical
nature, but medications and physical activity can control the prominent risk factors of
PAD (i.e., hypertension and dyslipidemia) and slow or halt the progression of the disease
as well (American Heart Association, 2009a).
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Chronic Exercise and PAD in DM: A Closer Look
Aerobic exercise training
Although aerobic exercise bouts can be painful to individuals with PAD due to
claudication effects (Gardner & Montgomery, 2008), aerobic exercise training can
improve walking time and distance and delay the onset of claudication signifying a halt in
the progression of the disease (Imparato, Kim, Davidson, & Crowley, 1975). For
example, Hiatt and colleagues (1994) demonstrated that a 12 week treadmill training
program (3 hours per week at an intensity sufficient to produce claudication) increased
maximal walking time by approximately 74% in individuals with PAD. An additional 12
weeks, using the same individuals performing the same exercise program, increased their
maximal walking time by approximately another 49% (Hiatt, Wolfel, Meier, &
Regensteiner, 1994). Upper extremity aerobic training programs appear to increase
ambulatory function as well by improving maximal walking distance. For example,
Treat-Jacobson and colleagues (2009) investigated 41 individuals with PAD (15 of whom
had DM) performing supervised arm-ergometry exercises, treadmill walking or both for
12 weeks (3 hours per week). Findings suggested that arm-ergometry performed for 60
minutes (cycles of 2 minute cycling at 10 watts below maximum ability, followed by a 2
minute rest period) increased maximal walking distance by approximately 53% (TreatJacobson, Bronas, & Leon, 2009). Furthermore, treadmill walking for 60 minutes (cycles
of 2 mph walking until claudication, followed by rest until pain relief) and a combination
of both exercise programs increased maximal walking distance by 69% and 68%,
respectively (Treat-Jacobson et al., 2009). Another study further supported these findings
by concluding that after 24 weeks of bi-weekly upper and lower extremity aerobic
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exercises (85-90% maximal oxygen uptake) individually increased maximal walking
distance by approximately 30% (Zwierska et al., 2005).
Resistance exercise training
In addition to delaying the onset of claudication, individuals with PAD who
undergo a resistance training program can reap muscular strength and aerobic endurance
benefits. For example, Wang and colleagues (2009) implemented a maximal lower leg
specific strength training program in individuals with PAD, whereby participants
performed 4 sets of 5 repetitions (85-90% of 1 repetition maximum) on a leg press 3
times per week for 8 weeks (Wang et al., 2009). The participants increased their
muscular strength, as evidenced by an increase in their 1 repetition maximum by
approximately 31% (Wang et al., 2009). Walking economy (the rate at which oxygen is
consumed during a walking session) increased by approximately 9.7% (Wang et al.,
2009). Other studies using lower extremity resistance exercise training in PAD also
found increases in ACD (increased approximately 36%) and maximal walking time
(increased approximately 49%) (Hiatt et al., 1994; McDermott et al., 2009), as well as
stair climbing endurance (increased approximately 15.0 points on a physical functioning
test) (McDermott et al., 2009).
Effects of aerobic and resistance exercise training on the pathophysiology of
PAD
PAD is, once again, the structural changes in arterial walls (usually inflammation)
(American Heart Association, 2008b) influenced by dyslipidemia and characterized by
endothelial dysfunction (American Heart Association, 2008a). The lack of progression of
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PAD during an exercise regimen could be attributed to an alteration of an individual's
lipid profile and improved endothelial function and vasodilation.
Aerobic and resistance exercise lowers triglyceride levels through a process
known as lipolysis by breaking down triglycerides into free fatty acids that can be used
for fuel. Lipolysis is activated with increased sympathetic nervous system (a branch of
the autonomic nervous system that increases its activity during exercise and stress)
stimulation which in turn promotes the release of norepinephrine which stimulates
receptors on adipose and/or skeletal muscle tissue. The binding of norepinephrine to
these receptors activates the enzyme adenyl cyclase which converts adenosine
triphosphate into the cyclic adenosine monophosphate that is responsible for activating
protein kinase A. Activated protein kinase A phosphorylates hormone sensitive lipase
which acts on triacylglycerol (triglyceride). A series of lipase reactions occur and the
compound which was once triacylglycerol is now a glycerol molecule and three free fatty
acid molecules (see Figure 18). The lipolysis causes the triglyceride levels to decrease
and creates fuels that can be used for energy. (Large & Arner, 1998; Lafontan et al.,
2008)
The lowered triglyceride levels cause an increase in HDL activity which is
already initially increased due to exercise (Dishman, Washburn, & Heath, 2004).
Exercise is known to increase the activity of the enzyme that works in conjunction with
HDL, lecithin cholesterol acyl transferase (LCAT) (Dishman et al., 2004). HDL is
created when apolipoprotein Al (APOA-1) binds with phospholipids (from membranes)
and cholesterol (from diet) that have exited a cell using a protein transporter called
adenosine triphosphate-binding cassette transporter (ABC) (it relies on energy from
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adenosine triphosphate to work) (Ikonen, 2008). This HDL is acted on by LCAT, from
the interstitial space, which esterifies the cholesterol to form globular (sphere-shaped)
HDL (Ikonen, 2008). The globular HDL accepts and esterifies cholesterol from other
tissues, arterial walls and LDLs with the help of LCAT (Ikonen, 2008). The globular
HDL can travel to liver cells or steroidogenic cells where the esterified cholesterol is
removed using a scavenger receptor and then excreted as bile or used in hormone
synthesis (see Figure 19) (Ikonen, 2008). As exercise increases LCAT activity, HDL
production and activity increase and LDL levels decrease (Borer, 2003).
The exercise-induced improvements in PAD and endothelial function are thought
to occur primarily through increased nitric oxide production (Sessa, Pritchard, Seyedi,
Wang, & Hintze, 1994) via a shear stress mechanism (Hambrecht et al., 1998; Sessa et
al., 1994), yet changes in resistance vessel structure and/or improved sensitivity of the
peripheral vasculature cannot be ruled out. During aerobic exercise, cardiac output
(product of heart rate and stroke volume) increases approximately 4-fold in order to meet
the blood and oxygen demands of the working muscles, and this causes repeated episodes
of vascular wall shear stress (Sessa et al., 1994). The mechanical shear stress of blood
(along with acetylcholine and bradykinin) is a stimulus (Hayden & Tyagi, 2002) that acts
on endothelial cell receptors triggering an increase in cytosolic calcium which activates
the eNOS to produce nitric oxide (Borer et al., 1998; Grijalva et al., 2008). Resistance
exercise also increases the amount of blood circulating to the muscle tissue causing an
increase in shear force and thus an improvement in endothelial dysfunction (Sessa et al.,
1994).
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Isometric exercise training
To date, no studies have examined the chronic effects of isometric exercise on
ICD, ACD and blood flow in individuals with PAD. However, as PAD is characterized
by intermittent claudication and the subsequent decrease in blood flow, studies examining
blood flow and endothelial function (including vasodilation) with isometric exercise
training are applicable to this clinical population. Blood flow is determined by the
product of (7ir~)v, ('r' refers to the radius of the blood vessel, V refers to the velocity of
the blood), and thus an increase in blood vessel radius (such as vasodilatory ability)
promotes an increase in blood flow.
Isometric exercise is novel form of exercise that is relatively under-investigated,
especially in clinical populations. Although the effect of both acute and chronic lower
extremity isometric exercise on blood flow is limited, studies have examined blood flow
post-acute isometric exercise in the arm. Thompson and colleagues (2007) observed a
change in blood flow immediately following one isometric hand grip (IHG) session
performed until the participant could no longer sustain the force within 5% of the target
value (20% MVC) for more than 2 seconds. The participants, male (n=18) and female
(n=20), displayed an increase in brachial blood flow from approximately 2 ml/min/100ml
to 6.7 ml/min/lOOml and 7.4 ml/min/lOOml, respectively (Thompson, Fadia, Pincivero, &
Scheuermann, 2007). The findings supported the work of McGowan and colleagues
(2006) who noted an increase in brachial artery blood flow immediately following an
acute bout of 30% MVC IHG exercise in individuals with hypertension (n = 17; 4, 2minute IHG contractions, each separated by a 4-minute rest period). An earlier study
conducted by Lind & Williams (1979) found a positive linear relationship between IHG
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intensity and forearm blood flow (2 seconds after the completion of the contraction) with
7 individuals performing the exercises at 20%, 40% and 60% MVC. The linear
relationship no longer existed at intensities >60% MVC, therefore the authors concluded
that high intensities were not beneficial for increasing blood flow (Lind & Williams,
1979).
Although, acute bouts of isometric exercise have shown to increase post-exercise
blood flow, they have also been associated with attenuation in endothelium-dependent
vasodilation (McGowan et al., 2006a). The increase in blood flow and subsequent
decrease in endothelium-dependent vasodilation has also been shown to occur with
chronic upper extremity isometric training as in another study conducted by McGowan
and colleagues (2006) where IHG was performed 3 times per week for 8 weeks. Chronic
upper extremity isometric exercise training is associated with an increase in resting
vasodilatory capacity and post-exercise blood flow (McGowan et al., 2006a), however,
when compared to an acute bout, neither the magnitude of the increase in post-exercise
blood flow is augmented, nor the transient reduction in endothelium-dependent
vasodilation is ameliorated.
The likely cause of reduced NO-mediated or endothelial-dependent arterial
vasodilation is peroxynitrite formation from a reaction between NO and reactive oxygen
species (ROS) (Li & Fostermann, 2000), which are created during ischemic conditions
(Alessio et al., 2000) such as isometric exercise. This phenomenon of increased blood
flow/decreased endothelial function could be due to an accumulation of metabolites, such
as adenosine (Costa & Biaggioni, 1998), that cause the dilation of blood vessels in order
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to decrease their local concentration (Herlihy, Bockman, Berne, & Rubio, 1976) thus not
requiring endothelial-dependent vasodilation.
Bilateral lower extremity isometric training studies are few and limited. One study
examined resting arterial blood pressure (BP) in 11 healthy individuals performing 4, 2
minute contractions at 30% maximum voluntary contraction 3 days per week for 8 weeks
and found that resting systolic and diastolic BP were reduced by approximately 4 mmHg
and 3 mmHg, respectively (Wiles, Coleman, & Swaine, 2009). However, during
isometric exercise performance BP has been known to increase. Increases in BP with
isometric exercise are dependent on both the size of the muscle employed and the
intensity of the contraction, and heart rate increases are exercise and intensity dependent
(Ray & Carrasco, 2000). As such, the BP and heart rate increases during acute isometric
bilateral lower extremity exercise may be of a magnitude great enough to elicit larger
increases in resting vasodilatory capacity via repetitive exposure to increased pulsatile
blood flow (Ray & Carrasco, 2000; Taylor et al., 2003). Chronic exposure to this larger
isometric stimulus (due to larger muscle mass), may elicit greater post-training
improvements in resting endothelial function while concomitantly ameliorating or
improving post-exercise endothelial dysfunction, as higher intensity upper extremity
isometric training can significantly reduce the formation of exercise-induced ROS (Peters
et al., 2006).
To add, acute isometric exercise bouts have been proven to significantly increase
shear stress rate (a stimulus responsible for the metabolic cascade necessary for
vasodilation and subsequent blood flow) from 25.2+/- 2.3 seconds"1 (baseline) to 41.9+/5.2 seconds-1(McGowan et al., 2006b). Therefore, repeated bouts of bilateral isometric
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exercise (training) could produce a larger and potentially longer lasting metabolic effect
of shear stress, allowing for a delayed reduction in blood flow during aerobic exercise in
a population with PAD and DM, more specifically, T2D. It is also possible that the
larger blood vessels of the lower extremities may require more time for metabolite
accumulation preventing or minimizing metabolite-aided vasodilation thus increasing the
reliance on endothelium-dependent vasodilation and fostering improvements in
endothelial dysfunction.
The increase in vasodilation and blood flow would allow individuals to exercise
aerobically for longer and reap the benefits for their T2D and PAD treatment. Increased
resting vasodilation would create a greater initial or pre-exercise blood flow potentially
increasing the margin between sufficient and reduced blood flow during exercise. As
reduced blood flow causes claudication, this would increase the time to claudication.
Increased post-exercise blood flow could be an indicator of improvement in physiological
processes responsible for defending against claudication. In this situation, isometric
exercise training may act as a bridge to aerobic exercise.
Pharmacological and Surgical Treatment Options for PAD
There is no true pharmacological treatment method for PAD, however, the risk
factors for PAD, hypertension and dyslipidemia, can be controlled or stabilized through
the prescribed use of pharmaceutical drugs. Anti-platelet (e.g., acetylsalicylic acid),
vasodilating (e.g., Cilostazol), cholesterol-reducing (e.g., Lipitor), and BP lowering
medications (e.g. ACE inhibitors) are often prescribed to individuals with PAD to cease
disease progression and aid in symptom remedy. (American Heart Association, 2009a)
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Surgical treatments are recommended for individuals with extremely severe,
debilitating, or aggressively progressing PAD. Angioplasty is a surgical procedure where
a balloon is inflated in the artery and compresses the lesion against the arterial wall
increasing the luminal space. A stent (wire mesh cylinder) can be inserted following
angioplasty to help keep the artery open to the new luminal diameter created. If the PAD
spans a large enough portion of the artery or completely impedes the artery's blood flow,
then a bypass can be performed. A bypass consists of rerouting the blood flow around
the blocked artery. A vein is taken from elsewhere in the body and used for this
rerouting. An artificial artery (made from Gortex) can be used instead of a vein.
(American Heart Association, 2009a)

1.3 Summary of Background
DM affects almost 200 million people worldwide and decreases age-expectancy
and increases the risk of cardiovascular disease (World Health Organization, 2008; World
Health Organization, 2009b; Grundy et al., 2009). Approximately 95% of the population
with DM are classified under the T2D sub-category (Berg, 1986) and suffer not only
from the disease, but from its complications, such as PAD (Canadian Diabetes
Association, 2008). Although not specific to DM populations, the weight of evidence
suggests that exercise as an intervention can decrease the symptoms of PAD (e.g.,
claudication) (Zwierska et al., 2005; Hiatt et al., 1990; Hiatt et al., 1994). However, the
information available on the effects of isometric training on PAD and its symptoms in
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DM is limited. Isometric training studies have been shown to promote an increase in
resting vasodilation and post-exercise blood flow (McGowan et al., 2006a; McGowan et
al., 2006b; Thompson et al. 2007; Lind & Williams, 1979). As claudication is caused by
a reduction in blood flow (Gardner & Montgomery, 2008), and blood flow is calculated
as the product of (nv )v, ('r' refers to the radius of the blood vessel, V refers to the
velocity of the blood), increased resting vasodilation would create a greater pre-exercise
blood flow potentially increasing the margin between sufficient and reduced blood flow
during exercise, and increased post-exercise blood flow could be an indicator of
physiological improvement processes responsible for defending against claudication.
Taken together, the potential exists for bilateral lower extremity isometric training to be
an effective intervention for claudication caused by PAD in T2D.
At present, investigation into the effect of bilateral lower extremity isometric
training on blood flow in individuals with T2D and PAD with debilitating intermittent
claudication is limited. Individuals with T2D and intermittent claudication are often
unable to participate in any aerobic exercise or participate to a health-beneficial extent
due to low-intensity claudication onset. The effect of bilateral lower extremity isometric
training on claudication is also limited and warrants further investigation. Bilateral
isometric exercise training may act as a bridge to aerobic exercise.
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1.4 Thesis Objectives
The purpose of the proposed study is 1) to determine if isometric leg training
increases the initial and absolute claudication distances, and 2) to determine if increased
blood flow is a potential mechanism responsible for the observed improvements in
claudication distances.

1.5 Specific Hypotheses
The primary hypothesis of this study is that in diabetic individuals with PAD
bilateral lower extremity isometric training will increase initial and absolute claudication
distances (ICD, ACD). A secondary hypothesis is that increased blood flow to the
trained limbs is a potential mechanism responsible for the observed improvements in
claudication distances.

1.6 Clinical Relevance
The work of this thesis will provide a foundation for and better understanding of
the effects of bilateral lower extremity isometric training on PAD in persons with T2D.
The results of this research may provide new interventions and protocols for individuals
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suffering from PAD and claudication. In addition, the practice of bilateral lower
extremity isometric training may also promote better T2D management, as this form of
exercise may increase the locomotor ability necessary for the aerobic exercise programs
that help control hyperglycemia.
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CHAPTER 2: Lower Extremity Isometric Training and its Effect on
Type 2 Diabetic Claudication
MANUSCRIPT
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2.1 Introduction
Type 2 diabetes mellitus (T2D) affects over 180 million people worldwide (World
Health Organization, 2008), of which 1.7 million are Canadian (Statistics Canada, 2010).
These figures are only the reported cases and show a trend that displays a steadily
increasing affected population (Statistics Canada, 2010). T2D is a disease characterized
by elevated blood glucose (hyperglycemia) due to inadequate insulin action and
decreased insulin sensitivity (Weir & Bonner-Weir, 2004) and is associated with
numerous co-morbidities, a prominent one of which is peripheral arterial disease (PAD).
PAD is a progressive disorder defined by structural changes in blood vessels and is
associated with poor endothelial function (e.g., reduced nitric oxide (NO)-mediated or
endothelial-dependent arterial vasodilation) and dyslipidemia (abnormal lipid profile)
causing intermittent claudication (leg cramping) as a result of reduced blood flow during
aerobic exercise (American Heart Association, 2008). Up to an estimated 54% of the
T2D population have PAD (Faglia et al., 1998; Hirsch et al., 2001).
Aerobic exercise training is a cornerstone therapy in the management of T2D
(American College of Sports Medicine, 2010), and is associated with increased insulin
sensitivity (Oguri, Adachi, Ohno, Oshima, & Kurabayahi, 2009; Winnick et al., 2008)
and improved glucose regulation (Kennedy et al., 1999). PAD can also be successfully
managed with aerobic exercise training (Treat-Jacobson, Bronas, & Leon, 2009), and is
responsible for increased locomotive ability and reduced leg cramping in the PAD
population (American Diabetes Association, 2003). Treat-Jacobson and colleagues
(2009) found that 12 weeks of aerobic exercise training using arm ergometry, treadmill
walking or both, increased maximal walking distance (absolute claudication distance;
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ACD) by approximately 53%, 69% and 68%, respectively in a population of T2D with
PAD population. Aerobic walking exercise programs (3 hours of walking per week, at a
self-selected pace) lasting 12 have shown to increase maximal walking time by
approximately 74% in a population of PAD patients with and without T2D (Hiatt,
Wolfel, Meier, & Regensteiner, 1994).
Although aerobic exercise is the universally accepted exercise-form of treatment
and management in diabetic individuals with PAD, as these patients are often limited by
leg cramping, this form of exercise can be excessively challenging and, in some cases,
intolerable (American College of Sports Medicine, 2010). This often discourages
individuals from seeking out or adhering to aerobic exercise training programs.
A form of exercise that promotes prolonged increases in post-exercise blood flow
is isometric exercise, which is relatively under-investigated, especially in clinical
populations. For example, a single bout of isometric handgrip exercise increases blood
flow to the working tissues post-exercise in healthy and clinical (e.g., hypertensive)
populations using bilateral or unilateral, single and multiple contraction protocols at
varying intensities (Lind & Williams, 1979; Thompson et al., 2007; McGowan et al.,
2006a), yet it is also associated with an acute attenuation in endothelium-dependent
vasodilation in the latter populations (McGowan et al., 2006a). Chronic upper extremity
isometric exercise training is associated with an increase in resting vasodilatory capacity
(McGowan et al., 2006a), however, with respect to acute bout hemodynamics, neither the
magnitude of the increase in post-exercise blood flow is augmented, nor is the transient
reduction in endothelium-dependent vasodilation is ameliorated with training. The likely
cause of reduced NO-mediated or endothelial-dependent arterial vasodilation is
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peroxynitrite formation from a reaction between NO and reactive oxygen species (ROS)
(Li & Fostermann, 2000), which are created during ischemic conditions (Alessio et al.,
2000) such as isometric exercise. This phenomenon of increased blood flow/decreased
endothelial function, irrespective of training status, could be due to an accumulation of
metabolites, such as adenosine (Costa & Biaggioni, 1998), that cause the dilation of
blood vessels in order to decrease their local concentration (Herlihy, Bockman, Berne, &
Rubio, 1976) thus not requiring endothelial-dependent vasodilation.
To date, there are few published bilateral lower extremity isometric training
studies and none on the effects on blood flow or endothelial function in T2D
claudication. One study examined resting arterial blood pressure (BP) in healthy
individuals performing 4, 2 minute contractions at 30% maximum voluntary contraction
3 days per week for 8 weeks (Wiles, Coleman, & Swaine, 2009). It is possible that
chronic exposure to a larger isometric stimulus (due to larger muscle mass), such as a
bilateral lower extremity isometric training protocol, may elicit greater post-training
improvements in resting endothelial function while concomitantly ameliorating or
improving post-exercise endothelial dysfunction, as higher intensity upper extremity
isometric training can significantly reduce the formation of exercise-induced ROS (Peters
et al., 2006). To add, acute isometric exercise bouts have been proven to significantly
increase shear stress (a stimulus responsible for the metabolic cascade necessary for
vasodilation and subsequent blood flow) (McGowan et al., 2006b), therefore, repeated
bouts of bilateral isometric exercise (training) could produce a larger and potentially
longer lasting metabolic effect of shear stress, allowing for delayed onset of blood flow
reduction during aerobic exercise in the T2D/PAD population. It is also possible that the
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larger blood vessels of the lower extremities may require more time for metabolite
accumulation preventing metabolite-aided vasodilation thus increasing the reliance on
endothelium-dependent vasodilation and fostering improvements in endothelial
dysfunction.
The increase in vasodilation and blood flow would allow individuals to exercise
aerobically for longer and reap the benefits for their T2D and PAD treatment. Increased
resting vasodilation may create a greater initial or pre-exercise blood flow potentially
increasing the margin between sufficient and reduced blood flow during exercise. As
reduced blood flow causes claudication, this would increase the time to claudication.
Increased post-exercise blood flow could be an indicator of improvement in physiological
processes responsible for defending against claudication.
At present, investigation into the effect of bilateral lower extremity isometric
exercise training on vascular function, including blood flow, in individuals with T2D and
PAD with debilitating intermittent claudication is limited. As previously mentioned,
individuals with T2D and intermittent claudication are often unable to participate in
aerobic exercise due to low-intensity claudication onset. In this situation, isometric
exercise training may act as a bridge to aerobic exercise.
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2.2 Purposes and Hypotheses
The purpose of the current study was to test the primary hypothesis that in
diabetic individuals with PAD, 8 weeks of bilateral lower extremity isometric training
will increase initial and absolute claudication distances (ICD, ACD). A secondary
purpose was to test the hypothesis that increased blood flow to the trained limbs is a
potential mechanism responsible for the observed improvements in claudication
distances.

2.3 Methods
2.3.1 Participants
This study was cleared by the University of Windsor Research Ethics Board
(REB#10-101) (see Appendix A), as well as the Windsor Regional Hospital Research
Ethics Board (see Appendix B). Individuals with concurrent T2D and PAD (diagnosed
by their primary care physician) aged 18 years and older, were recruited over an 11
month period to participate in this study. Patients were excluded if they had a lower
extremity amputation, walked with an assisting device (walker, cane, etc.), had heart
failure and/or a cardiovascular event (cardiac arrest, stroke, transient ischemic attack) or
hospitalization in the 12 weeks prior to the study (American College of
Cardiology/American Heart Association, 2004). Individuals were recruited from the
University of Windsor's general population, local physician offices, diabetes community
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programs, cardiovascular and chronic disease management programs, and the community
at large. Participants were recruited by means of a poster campaign (see Appendix C)
across the previously stated locations and via personal interaction.
Participant characteristics are presented in Tables 2.1-2.4. Forty individuals were
recruited to participate in the study, but rejected their participation due to time
constraints. Six individuals attended the initial visit, however, 1 individual was excluded
from the study due to a vascular surgery procedure and another individual dropped out
before the testing day. Ultimately, four individuals with T2D and PAD participated in
this study. All participants were Caucasian males, age 65.3±4.6 years (Mean ± SD) and
were regular exercisers (1.8±0.9 hours per day, 4.8±2.1 days per week). At the time of
the study, each participant was on standard pharmacotherapy for T2D and PAD,
however, no one was being treated for claudication pain. Only two participants
completed the 8-week intervention; due to circumstances beyond control of the
investigators, the remaining 2 participants completed a 7- and 6-week intervention,
respectively.

2.3.2 Study Design
This study was designed as a randomized, controlled trial; however, due to poor
recruitment, it was collapsed into a within-study design, using an intent-to-treat approach.
After inquiring about the study, participants were required to meet with the study
investigators at the Physical Activity & Cardiovascular Research (PACR) Lab (Room
#240, Human Kinetics Building, University of Windsor, ON, Canada) for an
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informational meeting. During the meeting, the participants signed a letter of information
(see Appendix D), signed an informed letter of consent (see Appendix E), completed a
medical questionnaire (see Appendix F) and were given the physical activity readiness
medical examination (PARmed-X) (see Appendix G) to be signed by their primary care
physician. Following the establishment of eligibility via the medical questionnaire and
PARmed-X, participants returned to the PACR Lab for familiarization of all testing and
training procedures and completed a personal history questionnaire (see Appendix H) and
signed a medical history release form (see Appendix I).
Testing Protocol
Testing took place over 1 day (approximately 1 hour), prior to (week 0) and
following (week 7 or 8 or 9) the intervention. To minimize the influence of external
factors on the tested measures, participants were asked to refrain from the consumption of
alcohol and caffeine for 12 hours prior (McGowan et al., 2006a) and smoking for 30
minutes prior (Primatesta et al., 2001). On the testing days, participants were required to
wear a short-sleeved t-shirt and shorts to ensure accuracy of measurements.
All testing took place in the PACR Lab. First, the participants rested in the supine
position for 10 minutes (Weatherley et al., 2006), after which arterial BP (Dinamap
ProCare 100, Critikon, Tampa, FL, USA; see Appendix J) was acquired using automated
arterial oscillometry in the following order: right brachial BP, left brachial BP, right
posterior tibial BP, left posterior tibial BP, right dorsalis pedis BP and left dorsalis pedis
BP. BP was taken once more in the same order to give two series of BP measurements.
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These measurements were used in the analysis of individual leg ankle-brachial index
(ABI; described below), a measure of PAD severity and disease progression.
Next, participants underwent a pre-walking popliteal artery duplex scan using Bmode and Doppler-mode ultrasound (Vivid i, GE Health, Pittsburgh, Pennsylvania, USA;
see Appendix K) (frequency=8.0/4.4 MHz; depth=4.0/5.0 cm; angle of isonation=60°)
with electrocardiogram (ECG) gating. Participants were required to lie in the prone
position with the backs of their knees accessible to the investigator. The diameter of each
popliteal artery and the concomitant blood velocities were collected continuously for 1
minute (Parker et al., 2006).
Once the necessary popliteal images were acquired, participants performed a
graded-exercise treadmill test as per the Gardner protocol (see Appendix L). In brief,
participants stated when they first felt pain/cramping in their legs (initial claudication
distance; ICD) and when the pain/cramping became too intense to withstand the test any
further (absolute claudication distance; ACD). Immediately after the completion of the
treadmill test, all participants underwent a post-walking popliteal artery duplex scan
following the same protocol as previously described.
Training Protocol
Participants trained 3 times per week, for a total of 6, 7 or 8 weeks. Each training
session took place in the PACR Lab under the direct supervision of an exercise trainer.
Participants were first asked if there had been any change in medication, nutrition or
physical activity routine (McGowan, et al. 2007) to ensure that these variables remained
unchanged throughout the study. Next, participants had their blood glucose levels
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analyzed using a commercially available blood glucose monitoring system (Abbott
Laboratories Freestyle Freedom Lite; see Appendix M) where blood was applied to a the
system's testing strip after being lanced with a spring-loaded lancet (Accuchek SoftClix;
see Appendix N). Individuals with a blood glucose reading of less than 4 mM were to be
given a carbohydrate snack to prevent possible adverse effects of hypoglycemia
(Canadian Diabetes Association, 2004).
After blood glucose analysis, resting BP and ABI (following the same protocol as
the testing days; data not used for analysis) were acquired after 10 minutes of supine rest.
After the establishment of a safe BP, brachial systolic BP of >200 mmHg or diastolic BP
of >110 mmHg (American College of Sports Medicine, 2010), participants performed
bilateral lower extremity isometric exercise using the Lower Leg Isometric Training
Apparatus (LoLITA; see Appendix O). Specifically, 4 sets of bi-legged, 2-minute
isometric lower extremity contractions at 30% maximal voluntary contraction (MVC;
determined at the onset of each training session via the Sustain Optimal Load Exercise
Software (SOLES) program contained within LoLITA) were performed, each separated
by 2-minute rest intervals (Wiles et al., 2009). Throughout the isometric exercise, BP was
monitored every 2 minutes, as a safety precaution. Immediately post-exercise, blood
glucose (as a precaution for hypoglycemia; same action plan as for the pre-training blood
glucose analysis), BP and ABI were assessed.

71

Data Analysis
Claudication Distances
As previously mentioned, ICD and ACD were determined using the Gardner
Protocol (see Appendix L). This standardized test is used clinically across all age groups
and disease states and has a within-subject variation of 15-25% for ICD and 12-13% for
ACD (Hiatt, Nawaz, Regensteiner, & Hossack, 1998). Prior to the commencement of the
graded-exercise treadmill test, participants were asked to only speak to the investigator at
the time of the initial onset of leg pain/cramping (ICD) and when they felt they could no
longer withstand the test (ACD). To control for the influence of motivation on time to
claudication, the investigator only spoke to notify participants of the incline increase
during the test and to acknowledge the claudication distances. Furthermore, participants
were blinded to their pre-intervention results following training.
Pre-Exercise and Post-Exercise Blood Flow
Blood flow was calculated separately for each artery using the product of (7ir2)v
where 'r' refers to the radius of the blood vessel and V refers to the velocity of the blood
(McGowan et al., 2006b). The radius of each artery was determined from the artery's
diameter. Specifically, three diameters (leading-edge to leading-edge) of the artery were
obtained at each R peak of the QRS-complex of the electrocardiogram for the entire
minute (Parker, Ridout & Proctor, 2006). The three diameters of each R peak were
averaged, and then that average was averaged with the other R peak averages (Parker,
Ridout & Proctor, 2006), then divided by two to give the artery's radius. Average mean
blood velocity was determined using the average of all the timed-average means of beat72

to-beat mean blood velocity of that artery (Vivid i, GE Health, Pittsburgh, Pennsylvania,
USA). Diameter and velocity raw data is presented in Tables 3.1 and 3.2.
To ensure measurement accuracy the same investigator performed all testing and
analysis procedures. To further enhance accuracy, the investigator used anatomic
landmarks and compared each participant's subsequent arterial duplex images to his
initial arterial duplex image.
Resting ABI
The resting ankle-brachial index (ABI) was determined with a calculation using
the various BP measurements obtained during the testing days. The highest brachial BPs
from each series and the highest ankle BP (dorsalis pedis or posterior tibial) of each leg
from the same series were used to calculate the ankle-brachial index (quotient of the
ankle arterial systolic BP and brachial arterial systolic BP) (Benchimol et al., 2004;
Beckman, Higgins, & Gerhard-Herman, 2006). The average ABI of the two series for
each leg was used. Resting ABI data is presented in Tables 3.3.
Blood Glucose
Blood glucose measurements were obtained and analyzed using a commercially
available blood glucose monitoring system (Abbott Laboratories Freestyle Freedom Lite;
see Appendix M) where blood was applied to a the system's testing strip after being
lanced from the participants' thumbs, index or middle fingers with a spring-loaded lancet.
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Statistical Analysis
Statistical significance was set at P<0.05. A Sign Test, a non-parametric test
which is designed to test results against predicted hypotheses, was performed on
claudication distance and blood flow data. A repeated measures analysis of variance, a
parametric test which measures the effect of an intervention on the same characteristic
under different conditions, was performed to assess the effects of training on the change
in blood glucose concentrations pre- and post-exercise. All tests were performed using
Predictive Analytics Software version 18 (PASW 18).

2.4 Results
ICD/ACD
Following bilateral lower extremity isometric training, ICD and ACD improved
by an average of 116.3±26.3% (pre: 165.9 ± 107.9 m to post: 338.0 ± 171.9 m) and
47.5±34.1% (pre: 390.3 ± 163.8 m to post: 559.3 ± 208.8 m), respectively. First, the
claudication distance data was statistically analyzed as two separate data sets in two
separate Sign Tests: 1)ICD (Z=1.5; p=.125) and, 2) ACD (Z=1.5; p=.125). Both data sets
displayed no statistical significance. As the Sign Test is a non-parametric test which does
not require data normality or homogeneity, and as ICD and ACD are related because they
both measure claudication distance, the two data sets were pooled into one to increase the
power of the data. Statistically significant increases were observed in the pooled
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claudication distance data (Z=2.475; p=.008). Guidelines for clinically significant
improvements in claudication distance(s) do not exist, therefore it is unclear if the
improvements classify as clinically significant as well as statistically. See Table 4.1.
Blood Flow
The effect of bilateral lower extremity isometric training on blood flow was
analyzed first by assessing each of the four separate data sets in four separate Sign Tests:
1) Pre-exercise right leg blood flow (Z=0; p=1.0), 2) Pre-exercise left leg blood flow
(Z=.5; p=.625), 3) Post-exercise right leg blood flow (Z=.5;p=.625), and 4) Post-exercise
left leg blood flow (Z=1.5;p=.125). As no statistical significance was detected with any
analyses, the four data sets were pooled into one. However, no statistically significant
changes in blood flow were observed (Z=.516, p=.607). See Tables 4.2 and 4.3.
ABI
Following training, there were neither statistically significant (all p>0.05) nor
clinically relevant changes in ABI (see Table 3.3). With respect to the latter, clinically, a
decrease in ABI of 0.15 indicates PAD progression (McLafferty, Moneta, Taylor, &
Porter, 1997; Criqui, Ninomiya, Wingard, Ji & Fronek, 2008), while an increase in ABI
of 0.15 is indicative of disease improvement (as seen post-surgical intervention)
(Eberhardt, 2003). Collectively, these data suggest there were no changes in ABI and
subsequently no disease progression.
Blood Glucose
The change in blood glucose concentrations from pre- to post-exercise session
remained unchanged with training, F(3, 54)= 1.39, p=0.255. See Table 3.4.
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2.5 Discussion
T2D is a highly prevalent chronic disease worldwide, and PAD is a common
comorbidity associated with the disease. PAD causes severe claudication pain in the
lower legs during activities as simple as walking, due to insufficient blood flow, and thus
negatively influences exercise capacity. This is concerning, as aerobic exercise is a key
form of treatment and management in T2D.
Isometric exercise is a novel form of exercise that is non-claudication promoting,
improves local resting vasodilatory function in clinical populations and increases local
post-exercise blood flow in healthy and clinical populations. Considering this evidence,
isometric exercise has the potential to be a viable intervention to increase ICD and ACD
by increasing blood flow to the trained tissues, subsequent to or independent of increased
local vasodilatory function. Furthermore, isometric exercise performed using a large
muscle mass may encourage greater improvements in those variables.
In support of the primary hypothesis, bilateral lower extremity isometric exercise
training performed at 30% MVC for 4, 2-minute contractions increased ICD and ACD.
The mechanism(s) responsible for this increase remain unclear, and as popliteal artery
blood flow remained unchanged in the current study, it is an unlikely mechanism. One
possible mechanism may be an increase in collateral blood vessel circuits (Murrant,
2008). Animal studies have shown that regular physical activity can increase the
conductance of these collateral vessels (Murrant, 2008), providing blood flow to areas
affected by PAD, and delaying claudication.
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Another possible and more probable mechanism for increased claudication
distance is ischemic adaptation. Individuals with PAD have low-functioning and
depleted amounts of vascular smooth muscle cells (VSMCs) (Bennett, 2006; Bennett,
Macdonald, Chan, Boyle, & Weissberg, 1998; Ross, Wight, Strandess, & Thiele, 1984),
leading to attenuated NO metabolism and impaired vasodilation. Sustained isometric
contractions can temporarily attenuate blood flow due to vascular constriction or
collapse, and exercises which cause ischemic conditions during their performance
increase NO availability (Kimura et al., 2007). Therefore, the more readily available NO
could travel to the mitochondrial cells of skeletal muscles where it causes attenuation in
oxygen consumption (Cooper & Brown, 2008) promoting greater oxygen availability for
muscle contraction-relaxation which delays muscle cramping.
As previously mentioned, popliteal artery blood flow remained unchanged with
training. It is possible that the participants had very severe endothelial damage that could
not be improved in the short-term training period. The progression of PAD (measured by
changes in ABI) correlates with increasing endothelial dysfunction and decreased
vasodilatory ability (Brevetti et al., 2003), however, individuals with PAD who have T2D
are very prone to arterial calcification (Chen & Moe, 2003) causing arteries to become
permanently stiff and rigid. Stiffening of the arteries causes artefactually elevated ABIs
(Bernstein & Fronek, 1982) masking the true severity of PAD and the extent of
endothelial dysfunction. Also, calcification alone causes arteries to have dysfunctional
endothelium and poor distensibility (Giachelli, 2004) and therefore, low vasodilatory
ability. However, this study did not measure endothelial function directly, therefore, this
theory cannot be fully supported nor ruled out. Although medication and diet was closely
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monitored throughout the study, specific medication and nutritional data were not
acquired, and thus one or more pharmacological and/or nutritional factor(s) may have
influenced the ability of the endothelium to change.
Another reason for the lack of blood flow improvement could be the location of
and/or the time course of the blood flow measurement. First, this study assessed blood
flow using only the popliteal artery, which is a conduit and not a collateral vessel. As
previously mentioned, collateral blood vessel circuits increase their conductance with
exercise and may be responsible for increased blood flow to areas below atherosclerotic
disease and arterial occlusions (Murrant, 2008). Second, blood flow during exercise was
not examined, therefore there is no data to determine or interpret hemodynamics during
exercise and at the time of claudication.

2.6 Limitations
This study was limited due to the sample size which affected the power of the
study. The study was originally designed as a randomized, controlled trial, but had to be
collapsed to a within-subject design. Without a control group it was difficult to assess the
magnitude of the isometric training intervention. Difficulty with participant recruitment
can be attributed to the training protocol as many of the prospects declined their
participation because of the amount of on-site time required (approximately 1 hour, 3
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times per week for 8 weeks). Some potential participants were living in elderly care
facilities with no mode of regular transportation to the facility.
This study employed an intent-to-treat approach. The primary goal of the study
was to increase both ICD and ACD in individuals with T2D and PAD, and although
performed with a small sample size and differing intervention lengths, the study did show
positive and statistically significant results with respect to claudication distances. These
results can be confidently defended because the tool used to assess claudication distance,
the Gardner Protocol, is widely used in both clinical and research domains, and has low
within-subject variability, even though participant self-motivation may skew data. This
study's results were also obtained from male participants with similar between-subject
characteristics such as age, ethnicity, physical activity level and prescribed medication.
To further add to the strength of this study's findings, the participants had differing
between-subject views with respect to their personal feelings of the study outcome,
ranging from feelings of disappointment (even with improved ICD/ACD) to success (as
one participant developed a continuing at-home program).
Assessment of two more variables, blood flow during exercise and endothelial
function, would have provided us additional data and possibly more insight into the
mechanisms causing increased ICD and ACD in this population. Blood flow during
exercise could not be measured as it is difficult to perform duplex ultrasounds and
acquire accurate images on participants in motion, particularly on a treadmill. Regarding
endothelial function, current non-invasive methods of measurement use prolonged
suprasystolic cuff occlusion of the limbs (Parker, Ridout, & Proctor, 2006). Although
this method is accurate, it is not reasonable for individuals with T2D and PAD who are
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likely to suffer from neuropathy (Canadian Diabetes Association, 2008), resting leg pain
(Beard, 2000) and venous insufficiency (Donnelly, Emslie-Smith, Gardner, & Morris,
2000) which can make the procedure painful and unbearable. Also, prolonged occlusion
of the venous system and/or the use of an improperly fitted cuff can cause venous trauma
and initiate inflammation and phlebitis (blood clot formation) (National Institutes of
Health, 2011b), which in some circumstances can lead to a pulmonary embolism
(National Institutes of Health, 2011a).
Another limitation of the study was that the dosage of and time of injection of
insulin were not monitored. Insulin has vasoactive effects and can act as either a
vasodilator or vasoconstrictor (Eringa, Stehouwer, Merlijn, Westerhof, & Sipkema, 2002;
Verma, Yao, Stewart, Dumont, Anderson et al., 2001) which can cause it to interfere with
arterial diameters and subsequent measurement and analysis.

2.7 Conclusion
Bilateral lower extremity isometric exercise training can increase both ICD and
ACD in individuals with concurrent T2D and PAD, however, increased local blood flow
cannot be identified as the mechanism responsible for the improvement. Further research
is needed in order to replicate these preliminary findings, and to determine the processes
that cause increases in ICD and ACD following bilateral lower extremity isometric
exercise training. Future studies involving bilateral lower extremity isometric exercise
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and ICD/ACD should examine the combined blood flow of all the infrageniculate arteries
(rather than isolating one) and mitochondrial respiration.

2.8 Clinical Relevance
The findings of the present study provide a foundation for future large-scale
studies designed to better understand the effects of bilateral lower extremity isometric
training on PAD and its complications in persons with T2D. Although still in the early
stages of investigation, the results of this research will serve as a basis for future studies
designed to investigate blood flow and isometric exercise, potentially providing an
alternative treatment option for individuals suffering from PAD and claudication. The
practice of bilateral lower extremity isometric training may also promote better T2D
management, as this form of exercise may increase the locomotive ability necessary for
the aerobic exercise programs that help control hyperglycemia.
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Table 1.
Summary of the Differences Between Type 1, Type 2 and Gestational Diabetes

Characteristics

Type 1

Type 2

Gestational

Alternate Name(s)

Juvenile-onset,
Insulin-dependent

Adult-onset,
Non-insulin dependent

(none)

Prevalence

5-10% of diabetics

90-95% of diabetics

4% of
pregnant
women

Time of Onset

Before age 20

After age 40

During
pregnancy

Pathology

The body does not
produce insulin

The body is resistant to
insulin

The body is
resistant to
insulin

Note. The information is from "Diabetics Guide to Health and Fitness", by K. Berg,
1986, Champaign, IL, Life Enhancement Publications; and "Gestational Diabetes:
Preventing Complications in Pregnancy", by the Canadian Diabetes Association, 2009.
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Table 2.1
Participant Characteristics: Age, Sex and Race

Participant
1
2
3
4

Age (years)
70
60
63
68

Sex
male
male
male
male

Race
Caucasian
Caucasian
Caucasian
Caucasian

Table 2.2
Participant Characteristics: Peripheral Arterial

Disease-Related

Participant

Age
diagnosed

Pain
medication

Hypertension
medication

Hyperlipidemia
medication

1
2
3
4

unknown
58
47
unknown

No
No
No
No

Yes
Yes
Yes
Yes

Yes
Yes
Yes
Yes

Anticoagulation
medication
Yes
Yes
Yes
Yes

Table 2.3
Participant Characteristics: Type 2

Diabetes-Related

Participant

Age diagnosed

1
2
3
4

39
54
47
52

Oral
medications
Yes
Yes
Yes
Yes
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Insulin
began at age 39; ended at age 68
Never
began at age 60 and continuing
began at age 59 and continuing

Table 2.4
Participant Characteristics: Physical Activity History

Participant

High school sports Post-high school
(age 18-50 years)

Golden years (age
50+ years)

Football team,
basketball team,
wrestling team

Dancing (ld/wk)

Dancing (ld/wk)

1 hr walk (2d/wk)
1 hr water aerobics
(2d/wk)

None

Pick-up hockey
(ld/wk)

1 hr walk (2d/wk)

Football team

Recreational baseball
(1 d/wk)

1 hr water aerobics
(5d/wk)

None

Physically demanding
jobs (5d/wk)

Physically demanding
jobs
(5d/wk until age 63)
1 hr walk (3d/wk)
2 hr walk (4d/wk)

Note. Hour (hr), day (d), week (wk)
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Table 3.1
Raw Data: Popliteal Artery Diameters (cm)

Pre-Intervention
Participant
1
2
3
4

Pre-Exercise
Right Left
0.80 0.81
0.81 0.79
0.56 0.55
0.73 0.74

Post-Intervention

Post-Exercise
Right Left
0.79 0.80
1.22 0.87
0.5 0.54
0.7 0.78

Pre-Exercise
Right Left
0.79 0.79
0.80 0.79
0.58 0.59
0.71 0.74

Post-Exercise
Right Left
0.83 0.83
0.78 0.77
0.59 0.59
0.70 0.76

Table 3.2
Raw Data: Popliteal Artery Timed-Average Mean Velocity (cm/sec)

Pre-Intervention
Participant
1
2
3
4

Pre-Exercise
Right Left
1.10 2.66
4.65 6.54
10.24 14.86
6.32 5.12

Post-Intervention

Post-Exercise
Right Left
3.22 3.22
34.90 16.63
25.37 44.50
8.06 5.97

Pre-Exercise
Right Left
1.09 1.57
6.81 4.47
19.57 15.43
6.28 3.85

Post-Exercise
Right Left
3.93 2.20
10.38 12.71
33.48 23.34
3.74 6.01

Table 3.3
Raw Data: Resting Ankle-Brachial

Index

Pre-Intervention
Participant
1
2
3
4

Post-Intervention
Right Leg Left Leg
1.24
1.23
0.81
1.00

Right Leg Left Leg
1.10
1.13
0.83
1.08
0.78

0.67

0.77

0.73

Note. Ankle-brachial indices could not be determined for Participant #3 due to 'error display' on
oscillometer, and Participants #1 and 2 may have elevated ankle-brachial indices due to arterial
calcification.
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Table 3.4
Raw Data: Pre & Post-Exercise Session Blood Glucose Measurements (mM)
Session
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20

Participant #1
Pre Post
6.4
7.7
10.5
11.6
7.7
6.9
5.9
4.7
5.2
4.5
9.8
9.8
11.3 10.1
8.6
8.1
6.4
4.9
10.2
8.0
7.8
7.8
12.6
15.6
6.1
5.9
7.1
5.4
10.2
9.5
12.0
9.1
12.0
15.0
8.8
11.4
7.5
8.6
11.9
10.3

Participant #2
Pre Post
11.1
16.9
13.4
13.0
12.4
16.2
11.0
9.8
9.7
10.8
17.1
13.5
17.8
18.6
16.9
13.4
12.7
12.0
17.8
18.1
14.1
15.5
13.1
12.0
12.8
10.9
10.9
10.9
12.5
9.3
11.1
11.9
-

-
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Participant #3
Pre Post
8.2
8.9
6.0
5.7
6.7
6.7
6.8
7.8
6.0
6.2
8.3
8.3
7.1
7.2
10.8
7.9
8.1
6.1
11.4
11.1
5.7
5.9
4.4
4.4
6.1
6.8
5.5
5.0
8.8
8.2
10.1
11.3
8.2
13.8
6.5
5.8
6.6
6.8
5.8
5.2

Participant #4
Pre Post
11.8
10.9
6.2
4.9
6.9
8.2
8.9
7.5
9.0
1.1
7.9
6.1
12.1
10.3
8.2
7.1
6.6
6.9
9.9
9.7
7.3
5.7
6.3
5.7
9.1
8.5
8.6
9.1
9.2
10.6
10.7
10.4
12.1
12.3
7.0
6.9
8.1
7.3
-

-

Table 4.1
Results Table: Initial Claudication Distance (ICD)/Absolute Claudication Distance
(ACD) (mi)

Participant
1
2
3
4

PreIntervention
ICD
0.07
0.20
0.09
0.05

PreIntervention
ACD
0.18
0.39
0.23
0.17

PostPostIntervention
Intervention
ICD
ACD
0.17
0.35
0.36
0.53
0.20
0.26
0.11
0.25

Table 4.2
Results Table: Pre-Exercise Blood Flow (ml/sec)

Participant
1
2
3
4

PreIntervention
Right Leg
0.55
2.46
2.52
2.72

PreIntervention
Left Leg
1.37
3.29
3.66
2.20

PostPostIntervention
Intervention
Right Leg Left Leg
0.55 0.79
3.42 2.14
5.17 4.08
2.56 1.65

Table 4.3
Results Table: Post-Exercise Blood Flow (ml/sec)

Participant
1
2
3
4

PreIntervention
Right Leg
1.58
4.08
5.81
3.85

PreIntervention
Left Leg
1.62
10.11
10.19
2.85
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PostPostIntervention
Intervention
Right Leg Left Leg
2.18 1.16
4.96 6.07
8.85 6.17
1.44 2.73

Figures
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Elevated blood gheose
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Sensed by pancreatic cells
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I

Pamcresj secrete insulin

Increased ^ucese uptake by cells

Figure 1. The Negative Feedback System of Contal for Blood Glucose. The blood ghicose
ceocentratioB is elevated by eating and this elevation is sensed by pancreatic eels which secrete
insulin in response to the elevation. The secreted insulin inftoenees inoessed glucose uptake by
cells and, in mm. reduces and retams the blood glucose concentration to monad.
Nole.TbE mianwHaa is fojm "Physiology of Stress", by M. Asenta, i9Z5r New Yoik, NY, H s m Sciences Press.
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Figum 2 Glycolysis LB the Sacroplasm of tbe Beta Cell Thefiguredepicts the pathway by
which pyruvate is cieatedfromgincose-6-phospliate, and the enzymes (in italics) acting on each
new molecule m the pathway. Also shown is the energy compound, adenosine triphosphate and
when it is produced (from adenosine diphosphate) or Bsed (broken down to adenosine
diphosphate).
Nine. H e infmmsitism n fesus "Exercise Fbyaatogy. Ttosif SEd AppfcirtiGii to fitness and Pertammce", by S.
Powers & E Bowley, 2®®§, New York, KY. McGnw-Hffl.
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Figure:
t i. The Kreb' s Cycle m a Mkocomdrion of the Cell. ThefipEredepicts the pathway by
whicht ppyruvate is converted into different molecules allowing for the production of the energy
caDapoond adenosine triphosphate (ATP) andreducingequivalents Bkotinaaaide adenine
diimcleotide with 2 hydrogen ions (KADH+H) andflavinadenine dinudeotide with 2 hydrogen
ions (FADf&) from the compotmis adenosine diphosphate (ADP), nkotinamide adenine
dimicleotide (NAD) andflavinadenine dimucteotideffAD) respectively. The ie&iciiig
equivalents will travel to the electron transport chain to produce more ATP. Also shown are the
enzymes (in italics) involved in the reactions.
NMe. Tise iufiKmnum is fan ""Exercise Physiology: Ttaijy ani AgpbuiHai to 1
i & E. Howtay, 2009, Ksw York, NY, McGraw-HHL
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Figure 4. The Eiecsroa Transport Chain ia a Mitochondrion. Thefiguredepicts the breakdown
of the reducing equivalents nicotinamide adenine dnmcfeonde and 2 hydrogen JOBS (NADH-i-H)
m&flavmadenine dinucleotide and 2 hydrogen ions (FADH;) by their respective enzymes (in
italics). Also illustrated are electrons (2e-) traveling through the transport chain providing the
energy to pinup hydrogen ion? (H+) into the outer compartment of the mitochondrion. The H- is
brought back into the iaaer compartment using adenosine triphosphate (ATP) synthase whose
action is coupled with the actions of the carrier proteins which transport phosphate ions (P) and
adenosine diphosphate molecules (ADP). The enzyme cytochrome oxidase catalyzes the
reaction of water (HzQ) production.
The infonrntism is torn "Exera.se PfaysioUsgy: Theory m& ApplicaHon to
& E. Htnriey, 2BEB, New York, NY, McGraw-IWl
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Figum J.Beta Cell Glucose Uptake and Insulin Release. Thefiguredepicts glucose entry into the
beta cell {via glucose transporter 2), and conversion into adenosine triphosphate (ATP) which
mhibits the A IP-sensitive potassium (Kr) channel, an action that causes cell membrane
depolarisrtio& and the opening of fc; voltage-gated calcium channel allowing calcium infinx.
Calcium activates the enzyme phospholipase C which acts on phosphotidy3iiuKitol-4,5biphosphate {PIP;) to cleave it into inositol- 1,4,5-tripbospste (IPs) and diacylglycerol IPj,
increase the release of calcium from the endoplasmic reticulam and this influences the process of
insulin exocytosis -tram the cell and into the extracellular space.
Norn. Has o t e a i x is fern '-Gfacose m a. Kfigokmr m GtaKS TxaaspoH ABBMBJ and Gtawe-Hrsnsporlei
mHNA m Hxmsm Beta-Cell Lines",fevK. laagato. K. Yssmb. G. Tosot, Y. Gkamsto, H. Yam, Y.
1992, Dobete, 41,592-597; ami "VsskiLge Koase MeasHremeas am»s &e PaaoBstk Befit-Gell 1 "
CdriiaBOiai^CtascterisSKs'", by I. Attrato, C. Drawn. G. Edfflestane. ft E. Saps, 1981.
Physfflkgy, 314.1*5-212.
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protein kinase B (xtm)
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^
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G1UT4 tmtstocstxsratocell I

Figure 6. Bisnlin-Stimulsted GLUT4 Translocation in a Muscle Cell. When msalin bands to the
insulin receptor on the muscle cell it activates tyrosine kinase wMch activates insulin receptor
substrate proteins. The insulin receptor substrate proteins bind to a i d subsequently activate
phosphotidylinositol-S kinase and this actios activates protein kinase B. Protein kinase B causes
the protein AS16CS to dissociate from the glucose transporter protein 4 (GLUT4). When bound to
GLUT4T AS1GG inMbits GLUT4 movements. Once AS160 is dissociated from GLDT4. GLUT4
translocation is able to occur.
JVtafelMsi
Uptakes.
774-785.

isfesm"Mechanisms of iSgh-C3aaK«.&i£ijlii-MsdiaSBd
TraiBport of Akt Amraam". bv K. Rotsiasoa & M. Base, 2fflJS.
& Metabolism, 294, S7S-SS1; smd "Models for Segulafioa by
Yeast", by G. Hanite. 2002. Nsstme Reww
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Figiire 7. Glycogenesis in Skeletal Muscle ind liver Celk. Glacose enters the e e l and is acted
on by the enzyme (in italics) hexokinase (in the skdetal muscle cell) or ghicokmase (in the liver
cell) which uses energy from adenosine triphosphate to produce giucose-fi-phosphase. Glucoses-phosphate is converted into glucose-l-phosphate by mntase. Pyrophosphorylase catalyzes the
reaction to produce uridine diphosphate from glncose-l -phosphate. Glycogen is then produced
from uridine diphosphate via the enzyme, glycogen synthase.
Jtta*. Has aifeimawas ssfcom"Buriogv: COHERES am!
E. SimoE & L Dickey, 2009, San Franasca, Person Ei
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{d* eSf, by V. CaqibeQ, J. S J E B , M. Tayfar,

acetyl CoA + acetyl CoA
ftoofon
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3-)^elnai-3-metfi)l ghaaiyl OaA mahtlase

^

acetoacetyl CoA '
*Ttos reaction also
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of
dmBckofidemdl

3-liydroxy-3-iitetlryl ghitaryl CoA

|

beta hydroxybutaiate

*• acetoacetate

«*Tte5raacMaalso
|
im-otas te omdaofflu of !

i— succinyl CoA

Lp. <mcciaate
| • — acetyl LoA 4 - |

Srafce

to Kreb's cycle

acetoacetyl CoA
L— acetyl CoA - * J

CoA

Figure S Ketone Body Formation in the Liver and Breakdown in Skeletal Muscle The
illustration depicts tbe OOEWTSKSII of 2 molecules of acetyl coenzyme A (CoA) mto the ketone

bodies betafayflroxybotarate,acetoacetate and acetone along with Ifae enzymes {m italics) that
catalyse each reaction. Acetone travels through l i e bkod stream to the kidneys to be expelled
walk beta byj&oxytaarate and acetoacetate enter the muscle cell to be broken down into acetyl
CoA and enter the Kreb s cycle.
&KL.SVSKSBS, 1962 BjodMrnical toimsaf, £4 211-216 sad 'Aspeos of KetogaMsss OHSrolsBsi Mechanism of
E«oa^BodyFcEH!atKmmIssiteedIte-ljwr&famaM!Mtea'
try Ml Lopes-Caradaso, I Mulder P Hermans S ran
dm E a ^ i , W KlazBga, E de Vnes-Akkerman. 0 aL I97S Mofecalar mS. Cslteta Boactemaij 9,155-173, and
iofExBinsei»hynology(3*1Ed),,,byW Metafile F Kateh&V Kaidi. 2086, Baltemsre, MD,
cottWIaums&WiBaiB
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I
inhibits vasoconstriction (attachment of myosin to actin)
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Figure 9 Vasodilation Caused by the Effect of Nitoc Oxide in a Smooth Muscle Cell Kitnc
oxide enters the smooth muscle cell and activates guanyl cyclase which conceits guanosme
triphosphate into cyclic guanojme monophosphate Cychc goanosine monophosphate inhibits
cakiam entry into the smooth moscle cell which mhiints vasocontraction by preventing myosm
attachment to sens thus causing vasodilanoa.
Note ItaiaisimawmBiraai'BiEfosePbysiijiogj Tta3iyami,A|sp]icatKMto
Powers & E Bowtey, 2089 KEK Yadt, NY, McGraw-»ffi *
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Figure 10. Formation of Nitric Oxide in wx Endothelial Cel. Acetylcholine, bradykinin or the
shearing stress of blood flow act on a receptor located on the endothelial cell membrane and this
caases in an increase i s calcium intracelMariy. The calcium activates nitric oxide synthase
wMch reacts with oxygen and this caases the activation of tetrahydrobiopierim which initiates the
interaction of L-araJEine and nicotinamide adenine dimicleotide. The interaction initiated by
tetrahydrobiopteriii produces L-citniillme and nitric oxide. Nitric aside then travels to the
smooth muscle cei to promote vasodilation.
Norn. Ibis utfatmaSMSEis from "SUsrariBg Yasosta Kane Omde tNamadcrabr L^rgamgeliBpniVBi the SyngJHEts
of ISKrnifttem OsmfealiDQ in PansEB with Periptignil Arterial Ckcksise Disease", by X. BOSH:, SJEode-Bogs, W.
Tbdafe. A. Creatag, K. Aiexmsiieir & L Frohcfa, 1998, Journal of the Amancaa Coltoege of Cardsolegy, 32.133 61334: ami " b Tvpe 2 Diabetes MelMns a Vascular Disease (Afteresclerapa&y} rah Hjpersiraraia a La*
MsEffissaaii? The Rote of NCS, NO and Sfidox Stress", by M. HsydHL & S. Tyagi 2002,<
v.2.
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I
increased protein srgumne N-methvl transferase

1
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• does sot occur

I
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imces mfe.

I

""'^j superoxide
transition metal * *" 'resets wift

FigHW 11. Formation of Reactive Oxygen Species instead of Nitric Oxide in tie Presence of
Dyslipidei3iia>''HypergryceniM. Dystipidemia and'or hypoglycemia cause the activity of protein
srgmine N-metnyl transferase to increase and produce assymetrical dnaethylarginine, a Larginine inhibitor. Decreased L-argiiaine coacentraiios leads to nicotinamide adenine
dmixleotide reacting oxygen (instead of L-arginiiie} and producing a superoxide. TMs
superoxide can react wMh a transition metal or nitric oxide {formed in another cell or pathway) to
form the superoxides hydroxy! or peroxynitiite respectively.
Nam. Tfc lntmratiaD. is fiora -losuto-SeastsiBDe. ADMA Levete ami Cudunratrilar Disease",fry» . Nash. 2002,
Journal offla>.Ameocaa Medical AssodMioo, 2S7,1451-1452; n d "Nitric Oxide, Sqienmfe and Perasnmtnte:
TbB Good, fee Bai m i the Ugly",fryJ. Bedsman & W. Koprpead, 199ff. AaKiicaa Journal of Pbysiofo^-, 271,
1424-1437; smd "Mtecksiadrial FarmaMMi of teems Oxygen. Specks", fry I.Tumms, 2003, Use Journal of
Physiology, 552,335-344.
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Figum 12 Foam Cell Framation from Low-Density Lipoproteins in an Fjidofhelial Cell. Lowdensity lipoprotein (LDL) enters the endothelial cell lad reacts with reactive oxygen species and
the enzymes sphmgomyeimase, smetciy piKHphohpase and myeloperoxidase to foim oxidized
LDL. The oxidized LDL is taken op by a macrophage through &e scavenger receptors SR-A
and CD3 to create a foam cell that migrates to the endothelial cell membrane
Mom Has iafijumattm usfesm."AMmmmmiity. Blasting die A&eroscferock Plaqae'; byK. Rase & M. A&asiswra,
2903, Harare MesJkme, 9,641 -642; and -THnstamg Molecular Btscovmes imp New Tberapies for
Aflsmraderosfe'*. bvD. R a t e & A. Dan^ieny. 2JOTB, Nature. 451. 904-91 J.
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Figure 13 Conversion of Dihytiroxy&cetoite Phosphate mto DiacylglceroL Gluocse enters the
cell sad through the process of glycolysis is converted mto dihydroxyacetoae phosphate
Dihydroxyacetone phosphate undergoesreactionscatalyzed by 012511165 (m itahcs) to prodace
dracyigloeFoL Some of these reactions mvolhre the addition of an acyi group that has been
removed t u n coenzyme A
Note The mfiramajm is fern "Proteus Kinase C Actraoim sissi 6m DepskipmeHi of Btabetic CampbcBBDHs", bj D
Koya & G King. 199S, Diabetes 4" 6, g59-E8S sad '•Tkreuhpenient of Use YneSYgiH SMJ PlsX Protems 111
Ptaptahpid Biasramescs m Bosk Baalhis SsiboHB and EsdierKhs Coif by M. Yostarara, T Oslraaa & K
28S~ BMC Microbiology, 7, 69. and "Basrase Fhysfltogr TSSOIT aad Applicaaim to 1
by 5 Powers &E Howie) 2009 Nen Ycsk NY, Mtfkaw-Hfli
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Figure 14. Protein Kinase C and Smooth Muscle Coatractien. Increased diacylglycerol
concentration causes increased activation of protein kinase C which increases the calcium
responsiveness in smooth musck contraction. As cafcram banfe to calmodulin, it activates
myosin Jight chain kinase which subsequently activates the myosin light chain. This allows
myosin to attach to actin and pal adjacent actin .filaments closer to each other. This occurs at
many locations m the smooth muscle cell causing if to coHtracL
Norn. HMS m&imatMm is fiom -•PrniMn Kinase C Artrraocaami Ae Development of DrabMk: QrapJicMijojis", toy
Amman? (10* e£f, by G. Tortura,
D. Kuya & G. King. 1998, Diabetes, 47,6, 859-BW; s
2095. Hobofeea, IL, Mm Wiley & SODS. Inc.
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Figure IS. Smooth Muscle Cell Proliferation Caused hy Hyperinsulinemaa., Insulin biacb is the insulin
leeeptor and activates tyrosine protein kinase which activates msulm receptor substrate proteins wMch
form a complex by binding to Sic homology 2 protein., growth factor receptor botmd protein 2 asd son rf
sevenless. The complex activates Hasfeyremoving euanosine dipio^iEate (GDP) and adding guasHjsine
triphosphate! (GTP) Has activates Raf 2nd mitogsa-jictivated protein linase (MAPK) kinase is
subsequently activated to initiate smooth msscie cell proliferation thorough MAPK.
Note. Use infiHQHtKM is from "IssulJB-Iadaced. Mirogeit-Aaivatei Prosem (MAP) Kkiase Ptespaotoe-1 (MKP-1)
Attemnies Iansim-SfiamlMed MAP Kmase Activity.. A Mechanism fin Fessfads Iohtbraaa. of Insulin Signaling".
by A Kasan. J. Bvaa, D- BaaaVopMibMv, K. Kamaa; & J. Ensari, 1997, Molecoiar EadsKractogy, 11,10, 15321543
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Figure 16 ATP Production m the Pho-sphagen Energy System, Adenosine tnphosphate (ATP) is
broken down during exercise into adenosine diphosphate (ADP) and a phosphate ictn (P) The
ADP cm read with creatine phosphate (with the aid of the enzvme creatine kinase) to prodace
ATP and creatine The ADP can slsoreactwith mother ADP molecule (with the aid of the
enzyme myokinase) to produce ATP and AMP (adenosine monophosphate)
Now Has uafonEHtHm is from 'Eserase Physiology Ttasre m i Application to Frtaess and Pw&mmaLeT in. S
Powas&E HowteT 20O9, New Tori KY McGraw-Hill
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Figure 17. GLUT4 Translocation caused by AMP Protein Kinase. Use ATP (adenosine
triphosphate)/ AMP (adenosine monophosphate) ratio decreases wilt exercise duetothe use and
breakdown of the fuel ATP into ADP (adenosine diphosphate), AMP, PPi (pyrophosphate) and P
(phosphate). AMP can also increase when ADP molecules accumulate (doe &J ATP breakdown)
w&reactwith each after to form ATP and AMP. The increase in AMP activates AMP proiem
kinase which is responsiblefromdissociating the inhibitory protein, AS 160,fromthe ^ucose
transporter (GLLT4) allowing it to translocate to the cell membrane.
i is from "SAMP-Atfiwed PtoteiB Kinase Aetraatkm caases GLUT4 TKmsiecaftoa in
Skeletal Masde", try E. Krarh-Kxaczek. M,ffirshuME..L Goodyear, & W. Windds, 1999, Diabetes, 4S, S, IM7lff71; amr-Gtasss Tinasfrart and S i s o s e Transports mMffid^
M. P&spet im>, Diabetes Cara, 13, 3,2SS-2S3. and "Modds IbcRegiilatkDa'by AMPSSKFlef Gtacoss Uptake m
Muscle mil Gene Espresaaa m Yessf, by G. Birdie, 20Q2, Nature REVIEW Mateodsr Cell Biology, 8, 774-7B5.
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figure 18. Lipolysis: The Breakdown of Triacylglycerol into Glycerol and 3 Fatty Acids. The
sjinpatteic nervous system and'or norepiEephiia act on a celblar membrane receptor causing
the activation of adenyi cyclase and thus producing cyclic adenosine monophosphate and
actn-ating cyclic adenosine monophosphate dependent kinase. Hormone sensitive lipase is
phosphmylated and subsequently activated by cyclic adenosine monophosphate dependent
kinase, and acts on toac3rlglyceroi to break it down to diacylglycerol and &freefettyacid. The
enzyme (in italics) diacykglyoerol lipase breaks diaeyiglyceroi into a free fatty acid and
menoacylglycerol which is broken down into glycerol and a free fetty acid.
Nme.Thzs m&MBmtism a,fe«m^Exercise H^sWogv. Theory and Application to Fitness ami PmSozmamx", by S.
POOTSS & E. Howley, 2009, New Task, NY, McGraw-Hill: "Principles of Human AaarsEny (10 a tSf, by G.
Xenons, 2905, Hobofaga. JL, Mm Wiley & Sons. Int.; "Essentials of Entose Paysrataey Q"1 Ed)", by W,
McArdte, F. Each & V. Katck 200*5. Baltimore, MD, Ljfpncoa Wiiikms & Wiltons.
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Figure 19 Creation and Lifespan of High-Density Lipoproteins High-density lipoproteins
{HDL) are created when alipaprotein Al combines with phospholipids and cholesterol
(trsnsparted out of hepatic or mteftmal cells by the adenosinefaphosphate-bindingcassette
transporter). HDL is acted on by the enzyme (in italics) lecithm cholesterol acyl transferase
(LCAT) to create globular HDL which travels tfaroagh She blood stream collecting cholesterol
from LDL (tow-density lipoproteins) and Mood vessel walls with lie aid of LCAT The
globular HDL then travels to the liver or steroidogenic cellstofather be excreted as bile or
convened into hormones, respectively
Trafficking aii!l<
Katun RKIEWS Material CeE Biology. 9. 12S-13S
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Appendix A. University of Windsor Review Ethics Board Consent

o
l o d a v ' s J M e lone 24 2010
Pntuipal investigator Martina kovacevse
Rl B Number 2«^?6
Research Project i ttl*_ Rl B» 10-101 I ovvct exfiemitv isometric training and its effects on t>pc
2 diabetic claudication
( I c a n i n t t Dale June 11 2010
Project r nd Date \ u g i m 01 2011
Milestones
Renewal Duc-2011 08 OKPcndmgl

1 his is to inform "sou that the 1 mversitv of W mdsot Research I chics Board (Rl B) which is organized
and operated dccoidinsi to the 1 ti I ouncil Folic v Statement and tht 1 mversitv of \\ sndsor Guidelines tor
Rese nch lnvolv m,a i iiiman Subiccts has granted approval to vour research protect on the d itt noted
thinv I his approval is valid ottlv until the Piofeet i ml Date
\ Progress Report oi I iiwl Report is due bv the date noted at>o\t I he Rt B mav ask tor monitoring
information at some time during the ptojectaf^s approval period
I Jut IIK* the course of the research no deviations from or changes to the piotoeol or consent form max be
initiated without pnoi written approval from the Rl B Minor ehamiUs) m ongoing studies will be
voiis'dered when siibmitud on the Request to Revise form
Investigates must also report prompt I v to the Rl B
at change' increasing the risk to the participant* s) and or affevisng significant!v die conduct of the siudv
b) all adverse and unexpected experiences of events that are both serious and unexpected
e 1 new mlormalion that mav adverxch affect the safet> of the subjects or the conduct of the smdv
I ornis for submissions notifications or changes ate available on the Rl B website
www itvurtdsor.c.{ rcb !1 vour data is going to be used for another pt oject it is necessarv to submit
another application to the Rl R We wish vou cverv success m voui research

"J
Pierre tkuiios Ph f>
% hair Research I tbics Board
Ihis is an otftctal document Please tttam the orwinai m vour files
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Appendix B. Windsor Regional Hospital Research Ethics Board Consent

>H*- WINDSOR REGIONAL HOSPITAL
* " * - = > OUTSTANDING CARE-NO EXCEPTIONS!
Research Ethics Board
Delegated Review
Review Date:

October 14, 2010

Project Title:

Lower extremity isometric training and its effect on Type 2
Diabetic Claudication

Principal Investigator: Martina Kovacevic, University of Windsor
REB File Reference:

10-201-21

Items Reviewed:
Ethics Submission Form dated October 6, 2010
Appendix C - Poster and Flyer
University of Windsor Ethics Approval Letter dated September 22, 2010.
Letter to Research Ethics Board - undated (received October 6, 2010.
Solicitation for participants for your research from Windsor Regional Hospital's Patients in the
Cardiac Wellness Program.
Approval has been granted for placement of Research Participant Recruitment Poster. Flyers
may be left in waiting area for any patient who chooses to take one. Eligible patients are not
to be identified by being distributed flyers as this would constitute a breach in patient privacy
and confidentiality.
This Research Ethics Board is constituted and operated in accordance with the Tri-Council Policy
Statement for Ethical Conduct of Research Involving Humans (TCPS), Canadian Food & Drug
Regulations, Division 5 (Clinical Trials), ICH Good Clinical Practice Guidelines E6, Personal Health
Information Protection Act, 2004 (PHIPA), U.S. Code of Federal Regulations Title 21 & 45.
Only Research Ethics Board members who are independent of the investigator(s) conducting the
study participated in decisions relating to this research.

COPY
Wallace Liang, MD., LLB., MHsc.
Chair, Research Ethics Board
Windsor Regional Hospital
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Appendix C. Poster Advertisement

oi Wmds.

Leg Pain /Cramping and Type 2 Diabetes Study
Be part of an important leg pain and cramping study;
• Are you over the age of 18 ?
• Do you have type 2 diabetes?
• Have you been diagnosed with peripheral arterial disease9
• Do you feel pain or crampmg in your legs after walking short distances?
If you answered YES, you may be eligible to participate in a research study
Please contact Martina Kovacevic at (519) 253-3000 ext 4979
kovacevm@uwindsor.ca
•study cleared by tte Umvaraly of Wm&nr HeiKris BMrs Board
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Appendix D. Letter of Information for Consent to Participate in Research

(J

University
of Windsc"

LETTER OF INFORMATION FOR CONSENT TO PARTICIPATE IN RESEARCH

Title of Study: Lower extremity isometric training and its effect on type 2 diabetic claudication
You are asked to participate in a research study conducted by Martina Kovacevic and Dr. Cheri
McGowan from the Department of Kinesiology at the University of Windsor as a requirement of Martina's
master's level thesis.
If you have any questions or concerns about the research, please feel to contact Martina Kovacevic at 519253-3000 ext 4979; or Dr. Cheri McGowan at 519-253-3000 ext 2451. For questions or concerns during
non-working hours, please contact Dr. Cheri McGowan at 734-904-8488.

PURPOSE OF THE STUDY
The purposes of this study are to determine if isometric leg (i.e., squeezing your calf muscles without moving
them) training will improve lower leg blood flow, delay the progression of peripheral arterial disease and
reduce the leg cramping that happens with walking in people with type 2 diabetes.

PROCEDURES
If you volunteer to participate in this study, you will be asked to:
INITIAL VISITS:
After expressing interest in this study, you will be asked to come to the Physical Activity and Cardiovascular
Research (PACR) Lab (Room #240, Kinesiology Building, University of Windsor, ON, Canada) to sign the
necessary forms, fill out a medical questionnaire and receive the physical activity readiness medical
examination to be filled out and signed by your doctor. At this time, you will also arrange a date to visit the
PACR Lab again to familiarize yourself with the equipment and lab, and find out whether you are in the
training (exercise) or non-training control (blood pressure monitoring) group.
TESTING DAY (approx. 1 hour):
You will be asked not to drink or eat alcohol or caffeine for 12 hours before the visit and not to smoke for 30
minutes before the visit. You will need to come to the PACR Lab dressed in a short-sleeved shirt, shorts
and comfortable walking shoes. You will be asked to rest for ten minutes, then blood pressure
measurements will be taken twice in each arm and four times in each leg. Following this, ultrasound
pictures of the popliteal arteries (large arteries in the back of the knee) will be taken on both legs using a
wand-like instrument covered in gel. You will then be asked to walk on a treadmill at 2 mph with an
increasing incline for as long as you feel comfortable. Ultrasounds pictures of your popliteal arteries will be
taken again once you complete the walk.
This testing day will be repeated at the end of the 8 week training period whether you are in the training or
non-training group.
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TRAINING DAYS FOR TRAINING GROUP (approx. 45 minutes):
Approximately 1 week following the testing day, you will be asked to visit the PACR Lab 3 times per week for
8 consecutive weeks for isometric leg training Prior to the training session a pre-exercise and post-exercise
finger-prick test to measure blood glucose to make sure that it is not too low (if it is you will be offered a
snack) The training will consist of performing exercises using a machine resembling a desk, where you sit in
a chair at the desk and press up on the desk top from underneath with your knees by trying to point your
toes The exercises will last for 2 minutes followed by a 2-minute rest period, and this will be done 4 times
The training day will begin with 10 minutes of rest and blood pressure measurements in the arms and legs
The exercises will be performed next and blood pressure measurements in one arm will be taken every 2
minutes Following the exercise, blood pressure measurements will be taken in the arms and legs again
TRAINING DAYS FOR CONTROL GROUP (approx. 30 minutes):
Approximately 1 week following the testing day, you will be asked to visit the PACR Lab 3 times per week for
8 consecutive weeks for blood pressure monitoring You will need to be dressed in a short-sleeved or
sleeve-less shirt and after resting for ten minutes, blood pressure measurements will be taken twice in each
arm and four times in each leg

POTENTIAL RISKS AND DISCOMFORTS
You may experience tendonitis in the tendons of the legs with isometric training, however, this risk is
minimal if the exercise is properly performed The blood pressure and blood flow measurement procedures
are non-invasive, but you may experience numbness or tingling with the cuffs while we are taking our
measurements You may also experience some tenderness in the areas of the finger-prick test

The intermittent claudication test (treadmill walking) is a safe test when used properly, and when participants
have been appropriately screened (which you will be once you have filled out the medical questionnaire and
your physician has completed physical activity readiness medical examination) Occasionally, for safety
reasons, we may have to stop the test In cases of emergency, you will be given first line treatment, as
appropriate Our laboratory's emergency action plan (EAP) is posted in the laboratory
Please contact one of the study investigators if you feel any adverse effects from completing any portion of
the study, and/or if you have any questions or concerns Study investigators will reinforce proper training
technique throughout the study If you experience any adverse effects during any testing procedure, first
line response will be provided

POTENTIAL BENEFITS TO SUBJECTS AND/OR TO SOCIETY
You will benefit from this study by having your blood pressure measured, recorded and tracked for a ten
week period You will be given this data upon request for your medical history This study will also provide
you with new and different exercises to help control symptoms of claudication

The scientific community and society will be able to use this study for information on non-drug-related ways
to control peripheral arterial disease and blood pressure because medications are usually expensive and
give the user unwanted side effects

COMPENSATION FOR PARTICIPATION
You will receive a University of Windsor Kinesiology Research t-shirt You will also be reimbursed for
parking fees and the potential fee for completion of the physical activity readiness medical examination and
medical release by their primary care physician If you were assigned to the non-training control group will
be given the chance to take part in the training exercises after the study is done
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CONFIDENTIALITY
Any information that is obtained in connection with this study and that can be identified with you will remain
confidential and will be disclosed only with your permission
You will be assigned an identification number. Your name will not be used in any information
collection, publication or presentation.

All paper and electronic data will be stored in a locked laboratory of the principal investigator Information
stored on computer will be password-accessible only, and will be available only to the study investigators
Upon publication of the study, all paper records will be shredded

PARTICIPATION AND WITHDRAWAL
You can choose whether to be in this study or not If you volunteer to be in this study, you may withdraw at
any time without consequences of any kind You may also refuse to answer any questions you don't want to
answer and still remain in the study The investigator may withdraw you from this research if circumstances
arise which warrant doing so

FEEDBACK OF THE RESULTS OF THIS STUDY TO THE SUBJECTS
Research findings will be available to participants by mail or email. Results will also be posted on
the University of Windsor's Research Ethics Board (REB) website in August 2011.

Web address
Date when results are available

SUBSEQUENT USE OF DATA
This data will not be used in subsequent studies

RIGHTS OF RESEARCH SUBJECTS
You may withdraw your consent at any time and discontinue participation without penalty If you have
questions regarding your rights as a research subject, contact Research Ethics Coordinator, University of
Windsor, Windsor, Ontario N9B 3P4, Telephone 519-253-3000, ext 3948, e-mail ethics® uwindsorca

SIGNATURE OF INVESTIGATOR
These are the terms under which I will conduct research

Signature of Investigator

Date
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Appendix E. Consent to Participate in Research

University ( /
of Windsor
CONSENT TO PARTICIPATE IN RESEARCH
Title of Study: Lower extremity isometric training and its effect on type 2 diabetic claudication
You are asked to participate in a research study conducted by Martina Kovacevic and Dr. Cheri
McGowan from the Department of Kinesiology at the University of Windsor as a requirement of Martina's
master's level thesis.
If you have any questions or concerns about the research, please feel to contact Martina Kovacevic at 519253-3000 ext 4979; or Dr. Cheri McGowan at 519-253-3000 ext 2451. For questions or concerns during
non-working hours, please contact Dr. Cheri McGowan at 734-904-8488.

PURPOSE OF THE STUDY
The purposes of this study are to determine if isometric leg (i.e., squeezing your calf muscles without moving
them) training will improve lower leg blood flow, delay the progression of peripheral arterial disease and
reduce the leg cramping that happens with walking in people with type 2 diabetes.

PROCEDURES
If you volunteer to participate in this study, you will be asked to:
INITIAL VISITS:
After expressing interest in this study, you will be asked to come to the Physical Activity and Cardiovascular
Research (PACR) Lab (Room #240, Kinesiology Building, University of Windsor, ON, Canada) to sign the
necessary forms, fill out a medical questionnaire and receive the physical activity readiness medical
examination to be filled out and signed by your doctor. At this time, you will also arrange a date to visit the
PACR Lab again to familiarize yourself with the equipment and lab, and find out whether you are in the
training (exercise) or non-training control (blood pressure monitoring) group.
TESTING DAY (approx. 1 hour):
You will be asked not to drink or eat alcohol or caffeine for 12 hours before the visit and not to smoke for 30
minutes before the visit. You will need to come to the PACR Lab dressed in a short-sleeved shirt, shorts
and comfortable walking shoes. You will be asked to rest for ten minutes, then blood pressure
measurements will be taken twice in each arm and four times in each leg. Following this, ultrasound
pictures of the popliteal arteries (large arteries in the back of the knee) will be taken on both legs using a
wand-like instrument covered in gel. You will then be asked to walk on a treadmill at 2 mph with an
increasing incline for as long as you feel comfortable. Ultrasounds pictures of your popliteal arteries will be
taken again once you complete the walk.
This testing day will be repeated at the end of the 8 week training period whether you are in the training or
non-training group.
TRAINING DAYS FOR TRAINING GROUP (approx. 45 minutes):
Approximately 1 week following the testing day, you will be asked to visit the PACR Lab 3 times per week for
8 consecutive weeks for isometric leg training. Prior to the training session a pre-exercise and post-exercise
finger-prick test to measure blood glucose to make sure that it is not too low (if it is you will be offered a
snack). The training will consist of performing exercises using a machine resembling a desk, where you sit in
a chair at the desk and press up on the desk top from underneath with your knees by trying to point your
toes. The exercises will last for 2 minutes followed by a 2-minute rest period, and this will be done 4 times.
The training day will begin with 10 minutes of rest and blood pressure measurements in the arms and legs.
The exercises will be performed next and blood pressure measurements in one arm will be taken every 2
minutes. Following the exercise, blood pressure measurements will be taken in the arms and legs again.
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TRAINING DAYS FOR CONTROL GROUP (approx. 30 minutes):
Approximately 1 week following the testing day, you will be asked to visit the PACR Lab 3 times per week for
8 consecutive weeks for blood pressure monitoring You will need to be dressed in a short-sleeved or
sleeve-less shirt and after resting for ten minutes, blood pressure measurements will be taken twice in each
arm and four times in each leg

POTENTIAL RISKS AND DISCOMFORTS
You may experience tendonitis in the tendons of the legs with isometric training, however, this risk is
minimal if the exercise is properly performed The blood pressure and blood flow measurement procedures
are non-invasive, but you may experience numbness or tingling with the cuffs while we are taking our
measurements You may also experience some tenderness in the areas of the finger-prick test
The intermittent claudication test (treadmill walking) is a safe test when used properly, and when participants
have been appropriately screened (which you will be once you have filled out the medical questionnaire and
your physician has completed physical activity readiness medical examination) Occasionally, for safety
reasons, we may have to stop the test In cases of emergency, you will be given first line treatment, as
appropriate Our laboratory's emergency action plan (EAP) is posted in the laboratory
Please contact one of the study investigators if you feel any adverse effects from completing any portion of
the study, and/or if you have any questions or concerns Study investigators will reinforce proper training
technique throughout the study If you experience any adverse effects during any testing procedure, first
line response will be provided

POTENTIAL BENEFITS TO SUBJECTS AND/OR TO SOCIETY
You will benefit from this study by having your blood pressure measured, recorded and tracked for a ten
week period You will be given this data upon request for your medical history This study will also provide
you with new and different exercises to help control symptoms of claudication
The scientific community and society will be able to use this study for information on non-drug-related ways
to control peripheral arterial disease and blood pressure because medications are usually expensive and
give the user unwanted side effects

COMPENSATION FOR PARTICIPATION
You will receive a University of Windsor Kinesiology Research t-shirt You will also be reimbursed for
parking fees and the potential fee for completion of the physical activity readiness medical examination and
medical release by their primary care physician If you were assigned to the non-training control group will
be given the chance to take part in the training exercises after the study is done

CONFIDENTIALITY
Any information that is obtained in connection with this study and that can be identified with you will remain
confidential and will be disclosed only with your permission
You will be assigned an identification number. Your name will not be used in any information
collection, publication or presentation.

All paper and electronic data will be stored in a locked laboratory of the principal investigator Information
stored on computer will be password-accessible only, and will be available only to the study investigators
Upon publication of the study, all paper records will be shredded
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PARTICIPATION AND WITHDRAWAL
You can choose whether to be in this study or not If you volunteer to be in this study, you may withdraw at
any time without consequences of any kind. You may also refuse to answer any questions you don't want to
answer ana still remain in the study. The investigator may withdraw you from this research if circumstances
arise which warrant doing so.

FEEDBACK OF THE RESULTS OF THIS STUDY TO THE SUBJECTS
Research findings will be available to participants by mail or email. Results will also be posted on
the University of Windsor's Research Ethics Board (REB) website in August 2011.

Web address:
Date when results are available:

SUBSEQUENT USE OF DATA
This data will not be used in subsequent studies

RIGHTS OF RESEARCH SUBJECTS
You may withdraw your consent at any time and discontinue participation without penalty. If you have
questions regarding your rights as a research subject, contact. Research Ethics Coordinator, University of
Windsor, Windsor, Ontario, N9B 3P4; Telephone: 519-253-3000, ext. 3948; e-mail: ethics ©uwmdsor.ca

SIGNATURE OF RESEARCH SUBJECT/LEGAL REPRESENTATIVE
I understand the information provided for the study Lower extremity isometric training and its effect on
type 2 diabetic claudication as described herein. My questions have been answered to my satisfaction,
and I agree to participate in this study. I have been given a copy of this form.

Name of Subject

Signature of Subject

Date

SIGNATURE OF INVESTIGATOR
These are the terms under which I will conduct research.

Signature of Investigator

Date
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Appendix F . Medical Questionnaire
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Appendix G. Physical Activity Readiness Medical Examination (PARmed-X)
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Appendix H. Personal Medical History Questionnaire
Type 2 Diabetes
1. When were you diagnosed with type 2 diabetes?
2. What is your current method ol control for type 2 diabetes7
3 How long have you been using the current method of control7
4. What were your previous methods of control7 (description, dates)

Peripheral Arterial Disease (PAD)
1. When were you diagnosed with PAD?
2. Are you currently taking medication to control PAD-related pain?
If yes, how long have you been taking this medication?
3. Are you performing any activities to help reduce PAD-related pain?
If yes, please describe:

Exercise
1. Do you exercise regularly7 Y/ N
If yes, what type of exercise do you perform and how often? _
If yes, how long have you been doing this exercise?

2. Where you active in previous years? Y/N
If yes, please describe the type of activity and its duration

The Study
1. Why did you join this study?
2. What encouraged you to complete the study's exercise program?
3. Did you find the exercise program helpful?
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Appendix I. Release of Medical Information

University C<F
ofW.pdsci
rt«*ngtomoid

Department of Kinesiology

RELEASE OF MEDICAL INFORMATION

authorize
to release any information regarding my medical condition to

Martina Kovacevic, BHK
Department of Kinesiology
University of Windsor
HK 240, 410 Sunset Avenue
Windsor, ON N9B 3P4
FAX: (519) 973 7056

Signature:

Date:

Details of information being requested:
health status with respect to blood pressure, type 2 diabetes, peripheral arterial disease
and cardiovascular health during the past twelve (12) months

o

I, Martina Kovacevic, have explained the details of the Release of Medical
Information Form to the participant
Signature :
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Appendix J. Automated Arterial Oscillometry Device
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Dinamap ProCarelOO, Critikon
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Appendix K. Duplex Ultrasound Machine
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Appendix L. Gardner Protocol
Gardner Protocol

The Gardner Protocol is a validated test (Gardner et al., 1991) used clinically to assess
intermittent claudication with the use of a graded treadmill.

The protocol is as follows:
1. The individual begins to walk on the treadmill at 2 mph at 0% incline.
2. While the individual walks at a constant 2 mph, the treadmill incline will increase
by 2% every 2 minutes.
3. The treadmill will continue to incline to a maximum of 14%.
4. As the individual is walking, he/she will notify the investigator when pain and
cramping are first felt in the legs (this is the initial claudication distance, ICD).
The individual will continue to walk.
5. Following the determination of the ICD, the individual will notify the investigator
at the appearance of maximal pain and cramping (this is the absolute claudication
distance, ACD). The individual will discontinue walking on the treadmill. The
ACD may occur before the maximum 14% incline.
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Appendix M. Blood Glucose Monitoring System
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Appendix N. Spring-Loaded Lancet

Accu-Chek Softclix
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Appendix O. Lower Leg Isometric Training Apparatus (LoLITA)
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Profile view of LoLITA

Frontal view of LoLITA
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